Page last updated: 2024-08-17

carbostyril and Disease Models, Animal

carbostyril has been researched along with Disease Models, Animal in 305 studies

Research

Studies (305)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (1.97)	18.7374
1990's	50 (16.39)	18.2507
2000's	69 (22.62)	29.6817
2010's	147 (48.20)	24.3611
2020's	33 (10.82)	2.80

Authors

Authors	Studies
Cheng, C; Cheng, J; Hao, P; Sui, W; Wang, X; Xing, Y; Xue, F; Zhang, C; Zhang, J; Zhang, M; Zhang, Y	1
Li, Q; Wu, X; Xin, M	1
Chadha, R; Dureja, J; Jindal, A; Karan, M; Singh, R; Tomar, S	1
Gall-Duncan, T; Hasuike, Y; Mehkary, M; Mochizuki, H; Nakamori, M; Nakatani, K; Pearson, CE; Tanaka, H; Tsuji, S	1
Coppes, RP; Du, L; Gao, S; Li, F; Li, K; Liu, F; Luo, Y; Pan, Y; Yao, Z; Zhang, D; Zhang, H; Zhu, J	1
Kamińska, K; Lech, MA; Lorenc-Koci, E; Rogóż, Z	1
Akpinar, HA; Bellenie, BR; Box, GM; Brennan, A; Bright, MD; Burke, R; Cheung, KJ; Davis, OA; de Haven Brandon, AK; de Klerk, S; Gowan, S; Harnden, AC; Hayes, A; Henley, AT; Hoelder, S; Huckvale, R; Johnson, LD; Kirkin, V; Le Bihan, YV; McAndrew, PC; Meniconi, M; Miller, DSJ; Pierrat, OA; Raynaud, FI; Rossanese, OW; Talbot, R; Tarantino, D; Valenti, M; van Montfort, RLM	1
Jones, RD; Li, H; Liao, J; Sun, L; Tong, X; Xu, D; Yang, GY	1
JeongWon, C; Jin-Sil, P; Kyung-Ah, J; Mi-La, C; SeungCheon, Y; Sun-Hee, H; Sung-Hwan, P	1
Kitanaka, C; Okada, M; Sanomachi, T; Seino, S; Suzuki, S; Togashi, K; Yamamoto, M; Yoshioka, T	1
Amakura, Y; Furukawa, Y; Haramiishi, R; Ito, H; Nakajima, M; Okuyama, S; Yoshimura, M	1
Huyan, T; Li, X; Liu, Q; Shi, Y; Su, J; Tie, L; Wang, D; Wang, Q; Wang, Y; Zhang, F; Zou, X	1
Alfuraih, S; Barbarino, A; Shamloo, K; Sharma, A	1
Beyer, C; Chrzanowski, U; Kaye, J; Kipp, M; Nyamoya, S; Schmitz, C; Steinle, J	1
Behrangi, N; Brendel, M; Jiangshan, Z; Kaye, J; Kipp, M; Nedelcu, J; Reinbach, C; Riedler, P; Rominger, A; Schmitz, C	1
Fujikawa, K; Fujikawa, M; Ikeda, F; Kanayama, S; Kitano, T; Matsumoto, T; Mori, S; Nakamura, A; Okamoto, K; Tabara, K; Tamura, R; Uratsuji, H	1
Kantevari, S; Krishna, VS; Marvadi, SK; Sridhar, B; Srilakshmi Reshma, R; Sriram, D; Surineni, G	1
Kinoshita, S; Nakamura, T; Nakayama, T; Sotozono, C; Tanaka, H; Tsukamoto, M; Watanabe, A; Yokoi, N	1
Caron, MC; Chiang, K; Davidson, S; Edward, LM; Eichler, EE; Gall-Duncan, T; Gallon, R; Hayakawa, H; Huddleston, J; Joshi, N; Lanni, S; Layeghifard, M; Lee, MYWT; Li, J; Luo, J; Masson, JY; Mochizuki, H; Munson, KM; Murata, A; Nakamori, M; Nakatani, K; Otabe, T; Panigrahi, GB; Pearson, CE; Prasolava, T; Sakata, A; Santibanez-Koref, M; Shlien, A; Takahashi, MP; Tanaka, H; Wang, X; Wold, MS	1
Chen, J; Cheng, Z; Fletcher, M; Jensen, BC; Liu, Y; Xia, P	1
Bhagwat, S; Choudhari, B; Deshmukh, NJ; Gupta, S; Karade, A; Patel, A; Patel, M; Patil, M; Sangle, GV; Shengule, SA; Thorve, D; Trivedi, J	1
Akahoshi, T; Guo, J; Mizuta, Y; Murata, M; Shirozu, K; Yamaura, K	1
Françoise, A; Héry-Arnaud, G	1
Callejas-Valera, JL; Gillenwater, AM; Richards-Kortum, RR; Schwarz, RA; Tan, MT; Vigneswaran, N; Wu, JG	1
Chen, H; Chowdhury, P; Gong, Y; Gorantla, S; Kumar, S; Nagesh, PKB; Sinha, N; Yallapu, MM; Zhi, K	1
Cai, Y; Li, X; Liu, J; Luo, J; Ma, X; Xia, Z; Xie, X; Xu, A; Yan, D; Ying, F	1
Arnt, J; Desmedt, A; Ducourneau, EG; Guette, C; Mombereau, C; Mondesir, M; Perrot, D; Piazza, PV	1
Abdel-Wahab, BA; Ali, FEM; Alkahtani, SA; Alshabi, AM; Hassanein, EHM; Mahnashi, MH	1
Choudhary, M; Malek, G	1
Cao, M; Liu, G; Liu, H; Liu, Q; Shu, Z; Xing, C; Yang, X; Zhang, J; Zhang, Y; Zhou, Y	1
Cao, X; Jing, L; Mou, S; Xu, N; Yu, Z; Zhang, C	1
Gu, JH; Ji, CH; Jiang, B; Liu, L; Liu, Y; Tang, WQ; Wang, Y; Zhao, J	1
Delgado, G; Granados-Falla, DS; Murillo, J; Robledo, SM; Torres Suarez, E; Upegui, Y	1
Chen, G; Li, S; Li, Z; Lu, L; Ma, S; Nie, W; Shan, C; Shu, C; Wang, H	1
Asakawa, AH; Brockmeyer, F; Casandra, D; Huang, L; Kyle, DE; LaCrue, AN; Maher, SP; Maignan, JR; Manetsch, R; Mashkouri, S; Monastyrskyi, A; Padin-Irizarry, V; Parvatkar, PT; Sakhno, YI; Zhao, Y	1
Hartgerink, JD; Leach, DG; Myers, JN; Osman, AA; Rangel, R; Ren, X; Shi, Y; Sikora, AG; Wang, B; Xie, TX; Young, S	1
Abdelsamie, AS; Bals, R; Berwanger, A; Blankenfeldt, W; Börger, C; Christmann, R; Empting, M; Hamed, MM; Hartmann, RW; Herr, C; Hirsch, AKH; Ho, DK; Horstmann, JC; Kany, AM; Koch, M; Lehr, CM; Loretz, B; Murgia, X; Röhrig, T; Rox, K; Schmelz, S; Schütz, C; Scrima, A; Siebenbürger, L; Wirth, M; Yahiaoui, S	1
Abdul-Salam, VB; Ahmetaj-Shala, B; Aldabbous, L; Dubois, OD; Duluc, L; Iannone, L; Mahomed, AS; Mitchell, J; Oliver, E; Storck, EM; Tate, EW; Wilkins, MR; Wojciak-Stothard, B; Zhao, L	1
Bassetti, M; Brüggemann, RJ; Bulitta, JB; De Waele, JJ; Felton, TW; Friberg, LE; Marchand, S; Nielsen, EI; Ramos Martín, V; Roberts, JA; Tam, VH; Tängdén, T; Theuretzbacher, U; Tsuji, BT; Wareham, DW	1
Cutter, GR; Fu, M; Hayardeny, L; Hussain, RZ; Jaramillo, TC; Lambracht-Washington, D; Miller-Little, WA; Powell, CM; Rosenberg, RN; Stüve, O; Takahashi, M; Zhang, S	1
Ahuja, M; Bridges, RJ; Chiorini, JA; Muallem, S; Swaim, W; Szymczak, M; Yin, H; Zeng, M; Zheng, C	1
Chopra, S; Das, S; Dasgupta, A; Jachak, GR; Reddy, DS; Singh, AK; Thakare, R; Vasudevan, N	1
Blusch, A; Brunner, J; Ellrichmann, G; Fatoba, O; Gold, R; Hayardeny, L; Hayden, M; Reick, C; Saft, C; Sehr, D; Winklhofer, KF	1
Adam, RJ; Comellas, AP; Li, X; Stoltz, DA; Vargas Buonfiglio, LG; Zabner, J	1
Jang, H; Jang, WS; Jin, YW; Kim, H; Lee, C; Lee, J; Lee, SJ; Lee, SS; Myung, H; Myung, JK; Park, S; Shim, S	1
Choi, YK; Chung, JW; Gweon, TG; Kim, BW; Kim, CW; Kim, HG; Kim, JS; Park, JH; Park, SM	1
Cope, ZA; Geyer, MA; Hellemann, G; Kwiatkowski, MA; Minassian, A; Perry, W; Sugar, CA; Young, JW	1
Ciapetti, P; Ciesielski, F; Cordeiro-da-Silva, A; Coron, RP; Costa, DM; Gaspar, L; KongThoo Lin, P; MacDougall, J; Major, LL; Pemberton, IK; Perez-Cabezas, B; Ramos, I; Ronin, C; Roura-Ferrer, M; Smith, TK; Tavares, J	1
Butovsky, O; Katsumoto, A; Lamb, BT; Miranda, AS; Ransohoff, RM; Teixeira, AL	1
Hanawa, T; Kawano, Y; Satoh, M	1
Aoki, K; Dogru, M; Higa, K; Igarashi, A; Kojima, T; Shimazaki, J; Shimizu, T; Simsek, C; Tsubota, K	1
Canton, R; Chouinard, L; Tarragó, C	1
Arañó, A; D'Aniello, F; Esquirol, LP; Lachamp, L; Tarragó, C; Zsolt, I	1
Ayzenberg, I; Dick, HB; Faissner, S; Gold, R; Joachim, SC; Kleiter, I; Kühn, S; Pedreiturria, X; Petrikowski, L; Reinehr, S; Stute, G; Wilmes, AT	1
Chen, W; Epshtein, Y; Jacobson, JR; Lederer, PA; Mathew, B; Wang, H; Zhou, T	1
Abou Alaiwa, MH; Carter, S; Grogan, B; Launspach, JL; McKone, EF; Singh, PK; Stoltz, DA; Welsh, MJ; Zabner, J	1
Babu, SPS; Hoerauf, A; Joardar, N; Mondal, S; Mukherjee, S; Pfarr, K; Schiefer, A	1
Ji, YW; Kang, HG; Kim, HC; Lee, HK; Moon, I; Noh, H; Song, JS; Yeo, A	1
Belinson, H; Garcia-Miralles, M; Hayden, MR; Pouladi, MA; Radulescu, CI; Sidik, H; Tan, JY; Tan, LJ; Yusof, NABM; Zach, N	1
Ashton, TM; Herbert, KJ; Higgins, GS; Pirovano, G; Prevo, R	1
Dogru, M; Igarashi, A; Kawakita, T; Kojima, T; Nagata, T; Ogawa, M; Shimazaki, J; Simsek, C; Tsubota, K	1
Bishai, WR; Gupta, S; Isaacs, JT; Krug, S; Leanderson, T; Pokkali, S; Srikrishna, G	1
Ajiboye, TO; Ibitoye, OB	1
Chao, YK; Cozza, G; Esposito, S; Ferrari, E; Garaci, E; Grimm, C; Guido, S; Kroemer, G; Luciani, A; Maiuri, L; Monzani, R; Oikonomou, V; Piacentini, M; Raia, V; Renga, G; Romani, L; Rossin, F; Silano, M; Spinella, MC; Tosco, A; Venerando, A; Villella, VR	1
Bereshchenko, O; Cuzzocrea, S; Di Paola, R; Gentili, M; Gugliandolo, E; Migliorati, G; Riccardi, C; Ricci, E; Ronchetti, S	1
Brković, B; Cook, JM; Divović, B; Ernst, M; Fabjan, J; Knutson, DE; Obradović, A; Savić, MM; Scholze, P; Sieghart, W; Steudle, F; Treven, M; Vasović, D	1
Day, AG; Elliott, BE; Ghaffari, A; Greer, PA; Hoskin, V; Kiefer, F; Madarnas, Y; Mewburn, J; Mullins, G; SenGupta, S; Turashvili, G; Varma, S	1
Cho, KA; Hahn, S; Kim, YH; Lee, Y; Park, JW; Park, WJ; Ryu, KH; Shin, SH; Woo, SY	1
Fu, R; Jiang, Y; Zhang, J; Zhou, J	1
Beekman, JM; Engelhardt, JF; Evans, TIA; Fiorino, DF; Gibson-Corley, KN; Gray, JS; Jiang, L; Liang, B; Moll, SR; Negulescu, P; Park, SY; Rosen, BH; Rotti, PG; Sun, X; Tran, DM; Van Goor, F; Vonk, AM; Winter, MC; Woody, L; Yan, Z; Yang, Y; Yi, Y; Zhang, Y; Zhou, W	1
Fujimoto, A; Uraoka, T; Yahagi, N	1
Ciftci, F; Eyuboglu, S; Sahan, B; Yaba, A; Yalvac, BI; Yilmaz, B	1
Furuya, M; Horiguchi, J; Ieda, M; Liaury, K; Miyaoka, T; Takechi, M; Tsuchie, K; Wake, R	1
Haruta, J; Kimura, K; Morita, Y; Orita, T; Sonoda, KH; Takeji, Y	1
Dontas, I; Karadimas, EV; Lampropoulou-Adamidou, K; Lelovas, P; Liakou, C; Papaioannou, NA; Triantafillopoulos, IK	1
Cichocki, M; Jarmuszkiewicz, Z; Kus, K; Nowakowska, E; Ratajczak, P; Woźniak, A	1
Abe, H; Amemiya, M; Hatano, M; Hayashi, C; Igarashi, M; Ikeda, D; Inoue, H; Kawada, M; Kinoshita, N; Masuda, T; Nomoto, A; Ohba, S; Usami, I; Watanabe, T	1
André, F; Bachelot, T; Baselga, J; Campone, M; Dalenc, F; Deudon, S; Hurvitz, SA; Kay, A; Perez-Garcia, JM; Porta, DG; Rugo, H; Shi, M; Smith, JW; Turner, N; Yovine, A; Zhang, Y	1
Kinoshita, S; Sotozono, C; Ueta, M; Yokoi, N	1
Choi, HS; Chun, HJ; Jeen, YT; Keum, B; Kim, CD; Kim, ES; Lee, HS; Lee, M; Lim, JY; Ryu, HS; Seo, YS; Sul, D; Um, SH	1
Boon, C; Chen, S; Deng, Y; Lim, A; Zhang, LH	1
Atsumi, E; Inayoshi, A; Inoue, K; Ishida, H; Kojima, Y; Miura-Kusaka, H; Mori, K; Nakasato, Y; Saku, O; Shinoda, K; Shirakura, S; Sugimoto, Y; Suzuki, N; Toki, S	1
Ibrahim, OM; Ishida, S; Kawakita, T; Kojima, T; Nagata, T; Ohguchi, T; Satake, Y; Shimazaki, J; Shimizu, T; Shirasawa, T; Tsubota, K	1
Diberto, JF; Fish, EW; Krouse, MC; Malanga, CJ; Robinson, JE; Stringfield, SJ	1
Bleickardt, CJ; Hodgson, RA; Hunter, JC; Jones, NT; Kazdoba, TM	1
Baasov, T; Bedwell, DM; Belakhov, V; Biswas, S; Chen, F; Dai, Y; Du, M; Hong, J; J Bridges, R; Jackson, LA; Mutyam, V; Rowe, SM; Schacht, J; Shalev, M; Tang, L; Xue, X	1
Funahashi, Y; Gotoh, M; Majima, T; Takai, S; Yamamoto, T; Yoshida, M	2
Calzetta, L; Cazzola, M; Matera, MG; Page, CP	1
Baldaia, MA; Berro, LF; Frussa-Filho, R; Hollais, AW; Longo, BM; Marinho, EA; Oliveira-Lima, AJ; Santos, R; Wuo-Silva, R	1
Hasebe, S; Kawamoto, N; Kikuta, M; Ogita, K; Shiba, T; Shuto, M; Yamaguchi, T; Yoneyama, M	1
Dudka, J; Oniszczuk, T; Poleszak, E; Serefko, A; Szopa, A; Wlaź, P; Wośko, S; Wróbel, A	1
Deng, XQ; Quan, ZS; Song, MX; Zheng, Y	1
Hahn, BH; Lourenço, EV; Palma-Diaz, MF; Skaggs, BJ; Wong, M	1
Aronica, E; Gorter, J; Potschka, H; Salvamoser, JD; Soerensen, J; van Vliet, EA; Zellinger, C	1
Ishida, T; Matsuda, T; Nakashima, T; Sako, N; Sakurai, K; Uematsu, N	1
Schulze-Topphoff, U; Varrin-Doyer, M; Zamvil, SS	1
Jacobsen, JR; Klein, U; Linsell, MS; McKinnell, RM; Moran, EJ; Nodwell, MB; Pfeiffer, JW; Thomas, GR; Yu, C	1
Arakaki, R; Eguchi, H; Enkhmaa, T; Hayashi, Y; Hotta, F; Ishimaru, N; Iwasa, A; Kudo, Y; Mitamura, Y; Mitamura-Aizawa, S; Yamada, A	1
Messmer, EM	1
Ambrosius, B; Gold, R; Hayardeny, L; Hayden, M; Pitarokoili, K; Schrewe, L	1
Arunagiri, P; Balamurugan, E; Rajeshwaran, K; Shanthakumar, J; Tamilselvan, T	1
Becker, AJ; Ben-Ari, Y; Bordey, A; Buhler, E; Bulteau, C; Burnashev, N; Cardoso, C; Delalande, O; Dorfmuller, G; Dulac, O; Gataullina, S; Goriounova, NA; Lozovaya, N; Milh, M; Minlebaev, M; Pallesi-Pocachard, E; Represa, A; Scavarda, D; Shityakov, S; Tsintsadze, T; Tsintsadze, V; Watrin, F	1
Adham, N; Gruca, P; Gyertyán, I; Kiss, B; Lasoń-Tyburkiewicz, M; Papp, M	1
Beshore, DC; Kuduk, SD	1
Aparicio, A; Cao, X; Chinnaiyan, AM; Corn, PG; Efstathiou, E; Iyer, MK; Kundra, V; Li Ning Tapia, EM; Logothetis, CJ; McKeehan, W; Navone, NM; Palanisamy, N; Ravoori, MK; Robinson, DR; Starbuck, MW; Tapia, EM; Troncoso, P; Vazquez, ES; Wan, X; Wang, F; Wu, YM; Yang, J; Zurita, AJ	1
Aguiar, DC; Almeida-Santos, AF; Duarte, ID; Ferreira, RC; Gobira, PH; Moreira, FA; Romero, TR; Souza, DP	1
Blessing, K; Kador, PF; Kawada, H; Kiyota, T; Winchester, L; Woolman, T	1
Bala, A; Chhibber, S; Harjai, K	1
Avula, SR; Bhatta, RS; Chhonker, YS; Mishra, V; Palit, G; Palnati, GR; Sashidhara, KV; Singh, LR; Singh, N; Swami, P	1
Eldredge, LC; Ramsey, BW	1
Curylofo, FA; Gonçalves, Vde P; Guimarães, MR; Ortega, AA; Ribeiro, DA; Rossa Junior, C; Spolidorio, LC	1
Amagase, K; Hashimoto, E; Itayama, M; Izuhara, C; Takayama, S; Takeuchi, K	1
Abrial, E; Bétourné, A; Etiévant, A; Haddjeri, N; Lambás-Señas, L; Lucas, G; Scarna, H	1
Ametamey, SM; Bieri, D; Herde, AM; Krämer, SD; Mu, L; Schibli, R; Slavik, R; Weber, M	1
Ebi, M; Hayashi, N; Joh, T; Katano, T; Kataoka, H; Mizoshita, T; Mori, Y; Ozeki, K; Shimura, T; Tanida, S; Tatematsu, M; Tsukamoto, H; Tsukamoto, T	1
Han, SH; Kim, HJ; Kim, JH; Lee, JH; Moon, W; Park, J; Park, SJ; Song, GA	1
Bodo, J; Danda, A; Gupta, N; Hill, BT; Hsi, ED; Lindner, D; Phillips, JG; Pore, D; Smith, MR; Yan, D	1
Gao, P; Li, R; Li, W; Liang, K; Ma, W; Wang, Y; Xu, X; Zhao, Y	1
Calzetta, L; Capuano, A; Donniacuo, M; Gritti, G; Martuscelli, E; Matera, MG; Orlandi, A; Rafaniello, C; Rinaldi, B; Rossi, F; Sodano, L	1
Arakawa, T; Fujiwara, Y; Kohata, Y; Nakahara, K; Shiba, M; Tanigawa, T; Tominaga, K; Watanabe, T; Yamagami, H	1
Akahoshi, Y; Fujiki, H; Ikeda, T; Iwanaga, Y; Miyazaki, S; Morooka, H; Watanabe, H	1
Nakashima, T; Sakurai, K; Sasabe, H; Sato, A; Sato, M; Shibamori, M; Uematsu, N; Umehara, K; Yamamura, Y	1
Eguchi, E; Kubo, M; Murakami, I; Nagaoka, K; Ogino, K; Zhang, R	1
Constantinescu, CS; Constantinescu, SE	1
Barile, E; Bosenberg, M; Brown, KM; Cheli, Y; Davies, MA; De, SK; Feng, Y; Grotegut, S; Hassig, CA; Hulea, L; James, B; Kim, H; Lau, E; Li, JL; Pellecchia, M; Pinkerton, AB; Ronai, ZA; Topisirovic, I; Yin, H; Zhang, T	1
El-Sisi, A; Zakaria, S	1
Bertolus, C; Caulin, C; Chabaud, S; Foy, JP; Goudot, P; Hong, WK; Lachuer, J; Lang, W; Lavergne, E; Le Texier, V; Lippman, SM; Perol, D; Saintigny, P; Thomas, E; Tortereau, A	1
Abe, N; Funato, H; Hirata, A; Iizuka, M; Jobu, K; Kadota, A; Miyamura, M; Nakai, M; Ogi, K; Shiraishi, H; Yagi, Y; Yokota, J	1
Hainke, U; Thomas, K; Ziemssen, T	1
Caron, NS; Deng, Y; Ehrnhoefer, DE; Hayden, MR; Qiu, X; Tsang, M	1
Bhole, A; Cowell, JK; Karp, J; Malek, S; Qin, H; Ren, M; Wu, Q	1
Alibana-Clouser, F; Antonyuk, SV; Brasseur, G; Capper, M; Donkin, D; Dovgin, S; Dubey, J; El Bissati, K; Esaa, F; Fishwick, C; Fraczek, L; Gordon, J; Hasnain, SS; He, Y; Hickman, M; Hood, L; Kent, M; Kim, E; Kim, TK; Lee, P; Lorenzi, H; Lukens, AK; Lykins, J; McLeod, R; McPhillie, M; Meunieur, B; Moulton, H; Muench, S; Roberts, CW; Sanders, J; Santos, T; Verma, SK; Wang, K; Weber, CR; Weiss, L; Wheeler, K; Wirth, D; Woods, S; Zhou, Y	1
Ito, Y; Nagai, N; Okamoto, N; Shimomura, Y	1
Biederman, RWW; Finley, GG; Jobe, BA; Kelly, RJ; Kosovec, JE; Landreneau, RJ; Matsui, D; Omstead, AN; Raj, M; Rao, RR; Zaidi, AH	1
Díaz-De-Alba, P; Docobo-Perez, F; Machuca, J; Ortiz, M; Pascual, Á; Recacha, E; Rodríguez-Martínez, JM	1
Caron, NS; Chuang, KH; Franciosi, S; Garcia-Miralles, M; Hayardeny, L; Hayden, MR; Hong, X; Huang, Y; Lin, RY; Papapetropoulos, S; Pouladi, MA; Tan, LJ; To, XV	1
Berg, J; Duscha, A; Esser, C; Gold, R; Haghikia, A; Mahmoudjanlou, Y; Massa, MG; Thöne, J	1
Gion, Y; Hanakawa, H; Ito, T; Makino, T; Marunaka, H; Matsukawa, A; Miki, K; Minoura, A; Nishizaki, K; Ohno, K; Orita, Y; Sato, Y; Tachibana, T; Takao, S; Takeuchi, M; Yoshino, T	1
Dong, C; Futamura, T; Hashimoto, K; Ma, M; Ohgi, Y; Ren, Q; Yang, C; Yao, W; Zhang, JC	1
Ashihara, E; Chauhan, J; Fletcher, S; Imayoshi, N; Nakata, S; Strovel, JW; Takata, K; Toda, Y; Yoshioka, M	1
Arnt, J; Geyer, MA; Milienne-Petiot, M; Young, JW	1
Avalos, N; Buczynski, MW; Irimia, C; Laredo, SA; Natividad, LA; Parsons, LH	1
Labrie, V; Lipina, T; Roder, JC	1
Avallone, H; Cao, K; Capell, BC; Chen, X; Collins, FS; Conneely, KN; Erdos, MR; Faddah, DA; Ganesh, SK; Kolodgie, FD; Nabel, EG; Olive, M; Qu, X; San, H; Tavarez, UL; Virmani, R	1
Bööhlendorf, B; Fecker, T; Höfle, G; Kunze, B; Sasse, F	1
Alén, F; Franco-Ruiz, L; Giné, E; González-Cuevas, G; López-Moreno, JA; Moreno-Sanz, G; Navarro, M; Santos, A	1
Aoki, Y; Ishiwara, M; Kohno, S; Mizutani, N; Nabe, T; Takagaki, H; Yoshino, S	1
Bonnefous, C; Chen, X; Hassig, CA; Nguyen, PM; Noble, SA; Payne, JE; Rao, TS; Rix, P; Roppe, J; Rozenkrants, N; Sablad, M; Severance, D; Shiau, AK; Smith, ND; Symons, KT; Walsh, JP; Wang, L; Yazdani, N; Zhang, Y; Zhuang, H	1
Bousquet-Mélou, A; Ferran, AA; Kesteman, AS; Toutain, PL	1
Bourin, M; Chenu, F; Hascoët, M; Prica, C	1
Adema, GJ; Berden, JH; Fransen, JH; Hilbrands, LB; Ruben, J; Stoffels, M; van der Vlag, J	1
Avenet, P; Bergis, O; Boulay, D; Griebel, G	1
Mavrikaki, M; Nomikos, GG; Panagis, G	1
Hedlund, PB; Roberts, AJ; Sarkisyan, G	1
Carrick, T; Feenstra, R; Kowal, DM; Kruse, CG; Lai, M; Marquis, KL; Pausch, MH; Reinders, JH; Robichaud, AJ; Rotella, DP; van der Neut, M; Yan, Y; Zhang, J; Zhou, P	1
Baldwin, R; Bartfai, T; Chang, J; Liu, T; Lu, X; Roberts, E; Sanchez-Alavez, M; Wasterlain, CG; Wu, S; Xia, F	1
Biojone, C; Casarotto, PC; Guimarães, FS; Moreira, FA; Resstel, LB; Zangrossi, H	1
Abekawa, T; Ito, K; Koyama, T; Nakagawa, S; Nakato, Y	1
Bae, S; Choi, JH; Choudhury, S; Kang, PM; Ke, Q; Koh, YY; Siu, PM	1
Cen, S; Huang, P; Jiang, JD; Li, CR; Li, GQ; Li, Y; Liu, JF; Lou, RH; Yang, XY; You, XF; Yu, LY; Yuan, M; Zhang, WX; Zhao, LX	1
Alcala, MA; Bartlett, DL; Kwan, SY; Lang, M; Lee, YJ; Petoud, S; Shade, CM; Uh, H; Wang, M; Weber, SG	1
Doçi, CL; Hasina, R; Lingen, MW; Mankame, TP; Wroblewski, K; Zhou, G	1
Hinrichs, D; Kelly, JX; Koop, DR; Riscoe, MK; Smilkstein, MJ; Winter, R	1
Calcagno, E; Carli, M; Invernizzi, RW; Mainini, E; Mainolfi, P	1
Abdel-Rahman, MH; Davidorf, FH; Li, PK; Massengill, JB; Meadows, S; Salem, MM; Yang, Y	1
Danysz, W; Dekundy, A; Gravius, A; Hechenberger, M; Mela, F; Nagel, J; Parsons, CG; Pietraszek, M; Tober, C; van der Elst, M	1
Adam, J; Black, D; Boucharens, S; Brown, AR; de Man, J; Epemolu, O; Fletcher, D; Huggett, M; Jones, P; Laats, S; Lyons, A; Morphy, R; Ray, P; Sherborne, B; Sherry, L; Straten, Nv; Westwood, P; Wright, J; York, M	1
De Carolis, L; Milella, MS; Nencini, P; Schepisi, C	1
Aoki, T; Kiso, T; Matsuoka, N; Tsukamoto, M; Watabiki, T	1
Docobo-Pérez, F; Domínguez-Herrera, J; López-Rojas, R; Pachón, J; Sánchez-Céspedes, J; Vila, J	1
Burda, K; Czubak, A; Kus, K; Nowakowska, E; Ratajczak, P; Zin, J	1
Choo, SP; Chow, PK; Chung, AY; Huynh, H; Linnartz, R; Ong, HS; Ong, R; Shi, MM; Soo, KC; Tai, WM	1
Deshpande, S; Gohil, P; Gohil, U; Thakkar, H	1
Ackland, ML; Danscher, G; Grosser, D; Knight, D; Lang, C; Michalczyk, A; Murgia, C; Perozzi, G; Roscioli, E; Ruffin, RE; Stoltenberg, M; Truong-Tran, AQ; Zalewski, P	1
Burton, B; Cao, D; Hoffman, BJ; Huang, CJ; Johnson, JP; Joubran, J; Seepersaud, S; Sussky, K; Urrutia, A; Van Goor, F; Worley, J; Yu, H	1
Ahlbrand, R; Bronson, SL; Grainger, M; Horn, P; McNamara, RK; Richtand, NM; Tambyraja, R	1
Chadman, KK; Guariglia, SR; Yoo, JH	1
Davies, JC; Pabary, R; Thursfield, R	1
Aharoni, R; Arnon, R; Eilam, R; Hayardeny, L; Saada, R; Sela, M	1
Mack, M; Mishra, MK; Silva, C; Wang, J; Yong, VW	1
Citraro, R; Davoli, A; De Sarro, G; Di Paola, ED; Gallelli, L; Russo, E	1
Chaumais, MC; De Man, FS; Dorfmüller, P; Eddahibi, S; Fadel, E; François, C; Girerd, B; Guignabert, C; Huertas, A; Humbert, M; Lecerf, F; Montani, D; Perros, F; Tu, L	1
Camp, M; Debrouse, L; Grant, SG; Gunduz-Cinar, O; Holmes, A; Hurd, B; Kiselycznyk, C; Mishina, M; Plitt, A; Todaro, A	1
Andoh, A; Fujimoto, T; Fujiyama, Y; Imaeda, H; Kasumi, E; Takahashi, K	1
Aza-Blanc, P; Barile, E; Bosenberg, M; Chin, L; De, SK; Feng, Y; Jackson, M; Krajewski, S; Lau, E; Pellecchia, M; Pinkerton, AB; Ronai, ZA; Ruller, C; Scortegagna, M; Williams, R	1
Cohen, TS; Dietrich, LE; Hernandez, A; Price-Whelan, A; Prince, AS; Recinos, DA; Sakhtah, H; Sekedat, MD	1
Aguiar, DC; Almeida-Santos, AF; Moreira, FA; Viana, TG	1
Cheson, BD; Gravell, AE; Wright, JJ; Zerivitz, K	1
Cho, SW; Hahm, KB; Han, SU; Kim, DY; Kim, JH; Kim, MW; Kim, YB; Lee, JS; Nahm, KT; Oh, TY; Song, YJ; Surh, YJ; Yoo, BM	1
Akamine, EH; Carvalho, MH; de Cássia Tostes, R; Fortes, ZB; Hohman, TC; Nigro, D	1
Rubinstein, E	1
Banevicius, M; Mattoes, HM; Nicolau, DP; Nightingale, CH; Xuan, D	1
Carlsson, A; Carlsson, ML; Nilsson, M	1
Akita, M; Hiratsuka, K; Izumi, M; Kurosawa, T; Sakai, T; Shibazaki, Y; Shindo, Y	1
Ji, X; Kurahashi, K; Murakami, S; Nishihashi, T; Trandafir, CC; Wang, A	1
Calzadilla, SV; Cox, BF; Fryer, RM; Gopalakrishnan, M; Hu, Y; Lin, CT; Marsh, KC; Preusser, LC; Reinhart, GA; Xu, H	1
Bokarewa, M; Carlsten, H; Jonsson, C; Svensson, L; Tarkowski, A	1
Böhle, A; Fornara, P; Jocham, D; Jurczok, A; Zacharias, M	1
Skuza, G; Wedzony, K	1
Denda, A; Inoue, M; Kirita, T; Kitayama, W; Kuniyasu, H; Morisaki, A; Yamamoto, K	1
Kato, S; Nishio, H; Okayama, M; Takeuchi, K; Tsubouchi, R	1
Cosi, C; Newman-Tancredi, A; Rollet, K; Tesori, V; Waget, A	1
Dashieva, DG; Elistratova, NA; Mikhaĭlova, LP; Mozhokina, GN; Sokolova, GB	1
Chizh, BA; Christoph, T; Englberger, W; Reissmüller, E; Schiene, K	1
Anderson, KD; Bonelli, F; Ciliberto, G; Holder, DJ; Kinose, F; Lamartina, S; Roscilli, G; Spence, SG; Thut, CJ; Toniatti, C; Vogt, TF	1
Aukerman, SL; Garrett, EN; Goldbeck, C; Heise, C; Lee, SH; Lopes de Menezes, DE; Louie, SG; Oei, Y; Peng, J; Shephard, L; Tang, Y; Wiesmann, M; Ye, H	1
Iwamura, H; Kaya, T; Matsui, T; Miyagawa, N; Ueda, Y	1
Fujimori, S; Futagami, S; Gudis, K; Hiratsuka, T; Kusunoki, M; Miyake, K; Nishigaki, H; Sakamoto, C; Shinji, Y; Shinoki, K; Suzuki, K; Tatsuguchi, A; Tsukui, T; Wada, K	1
Atsuda, K; Hibi, N; Matsui, H; Matsumoto, T; Nakamura, M; Takahashi, T; Tsuchimoto, K; Yamada, H	1
Kumakura, T; Maeda, T; Mori, T; Nagamoto, H; Nakashima, T; Takai, M	1
Arakawa, T; Fujiwara, Y; Hamasaki, N; Higuchi, K; Ishii, E; Kadota, S; Nagaoka, T; Oshitani, N; Sasaki, E; Tanigawa, T; Tezuka, Y; Tominaga, K; Watanabe, T	1
Fukuda, Y; Higashiyama, Y; Hirakata, Y; Kohno, S; Miyazaki, Y; Mizuta, Y; Ohno, H; Tashiro, T; Tomono, K; Tsukamoto, K; Yanagihara, K	1
Berti, F; Civelli, M; Manfredi, B; Razzetti, R; Rossoni, G	1
Alyaqoub, FS; Gunning, WT; Kramer, PM; Lubet, RA; Pereira, MA; Steele, VE; Tao, L	2
Altar, CA; Feltenstein, MW; See, RE	1
Aisaka, K; Kuraishi, Y; Maekawa, T; Nojima, H	1
Almond, SL; Armstrong, EJ; Brandon, NJ; Chiu, CS; Fradley, RL; Heavens, RB; Hutson, PH; Konno, R; Newman, RJ; Rutter, AR	1
Higashiyama, Y; Hirakata, Y; Izumikawa, K; Kohno, S; Miyazaki, Y; Mizuta, Y; Seki, M; Tomono, K; Tsukamoto, K; Yanagihara, K	1
Inaba, T; Shishikura, T; Shito, K; Uchida, M	1
Asencio, C; Candalh, C; Heyman, M; Laharie, D; Matysiak-Budnik, T; Mégraud, F; Ménard, S; Rullier, A; Vidal-Martinez, T; Zerbib, F	1
Acencio, MM; Antonangelo, L; Bumlai, RU; Marchi, E; Teixeira, LR; Vargas, FS	1
Aquaro, S; Balzarini, J; Cecchetti, V; De Clercq, E; Fravolini, A; Pannecouque, C; Perno, CF; Pollicita, M; Schols, D; Stevens, M; Tabarrini, O; Verbeken, E	1
Aoyagi, T; Hiroyama, M; Oikawa, R; Sanbe, A; Takeo, S; Tanoue, A; Wang, S	1
Guan, Q; Montrose, DC; Quilley, J; Rajagopalan, S; Smith, CJ; Zhao, H	1
Koob, GF; Pulvirenti, L; Wang, Z; Wee, S; Woolverton, WL	1
Denda, A; Kirita, T; Kitayama, W; Kuniyasu, H; Sasahira, T; Yamamoto, K	1
Breithardt, G; Cakir, Y; Eckardt, L; Engelen, MA; Haverkamp, W; Hilker, E; Milberg, P; Mönnig, G; Osada, N; Ramtin, S; Stypmann, J	1
Lagu, B; Lebedev, R; Pelton, PD; Pio, B; Yang, M	1
Bartlett, JB; Berg, S; Carey, F; Charles, AD; Convey, G; De Schoolmeester, J; Freeman, S; Loxham, SJ; Poucher, SM; Teague, J; Turnbull, AV; Walker, M	1
Ida, T; Kariyama, R; Kato, Y; Kumon, H; Maebashi, K; Mikuniya, T; Monden, K	1
Acosta, F; Cottagnoud, M; Cottagnoud, P; Gerber, P; Jiang, L; Nguyen, P; Phan, LT; Stucki, A; Wachtel, D; Wang, G	1
Arakaki, R; Hayashi, Y; Ishimaru, N; Kohashi, M	1
Concordet, D; Regnier, A; Schneider, M; Toutain, PL	1
Fuchikami, J; Takahashi, M; Takeuchi, Y	1
Aoki, Y; Ichinohe, A; Kamada, F; Kanno, J; Kojima-ishii, K; Komatsuzaki, S; Kure, S; Matsubara, Y; Mizoi, K; Nakahara, D; Narisawa, A; Oda, M; Shinka, T; Sugawara, T; Yokoyama, H	1
Harada, K; Hashimoto, M; Mimura, Y; Ogura, T; Oishi, T; Ota, Z; Otsuka, F; Yamauchi, T	1
Kanno, Y; Okada, H; Saruta, T; Suzuki, H	1
Irifune, K; Ishida, K; Kaku, M; Mizukane, R; Suyama, N; Takemura, H; Tanaka, H; Tomono, K; Usui, T; Yoshida, R	1
D'iakov, SI; Katsalukha, VV; Lebedeva, IK; Lukashina, AV; Raĭskaia, VA	1
Cynamon, MH; Klemens, SP; Rogge, MC; Sharpe, CA	1
Abe, H; Awaji, T; Hashimoto, K; Motomura, S; Wu, Z	1
Banerjee, DK; McDermott-Lancaster, RD	1
Ehrett, S; Friedland, IR; Hickey, S; McCracken, GH; Olsen, K; Paris, M	1
Abraham, WM	1
Church, MK; Holgate, ST; Hutson, PA	2
Currie, JL; Isakson, PC; Rao, TS; Shaffer, AF	1
Saito, H; Tomioka, H	1
Asin, KE; Bianchi, B; Britton, DR; Didomenico, S; Hodges, L; Hong, Y; Jenner, P; Lin, CW; Mahan, L; Michaelides, M; Mikusa, J; Miller, T; Nikkel, A; Shiosaki, K; Smith, L; Stashko, M; Williams, M; Witte, D	1
Baragi, VM; Basrur, PK; Black, W; Campbell, E; Carpenter, A; Gough, A; Hall, L; Johnson, R; Metz, A; Sigler, R; Tylor, J	1
Goto, S; Hara, K; Kondo, T; Makiyama, K; Murase, K; Sekine, I; Urata, Y; Zea-Iriarte, WL	1
Evans, LA; Norton, KA; Rinaldi, MT; Sutton, SC	1
Evans, LA; Genereux, PE; Gibbs, EM; Sutton, SC	1
Hirose, M; Iwazaki, R; Kitamura, T; Miwa, H; Miyazaki, A; Oide, H; Sato, N; Wang, XE; Watanabe, S; Yoshizawa, T	1
Makarova, OV; Mikhaĭlova, LP; Mozhokina, GN; Sokolova, GB	1
Destache, CJ; Pakiz, CB; Stoysich, AM	1
Chida, K; Hayakawa, H; Iwata, M; Kitazawa, H; Sato, A	1
Kishimoto, T; Matsushima, T; Miyashita, N; Nakajima, M; Niki, Y	1
Irikov, OA; Romanov, IuA	1
Izumi, K; Kawazoe, K; Mikamo, H; Sato, Y; Tamaya, T	1
Desaty, TM; Griffin, TJ; Heifetz, CL; Sesnie, JC; Shapiro, MA	1
Brück, W; Chen, V; Dalhoff, A; Kohlsdorfer, C; Nau, R; Schmidt, H; Schneider, O; Stuertz, K; Trostdorf, F	1
Belenkie, I; Semeniuk, LM; Tyberg, JV	1
Cohen, MA; Gage, JW; Huband, MD; Roland, GE; Yoder, SL	1
Arakawa, T; Kobayashi, K; Tarnawski, A; Yoshikawa, T	1
Arakawa, T; Kobayashi, K; Tarnawski, A	1
Hong, KW; Kim, CD; Kim, KE; Lee, WS; Rhim, BY	1
Iwata, Y; Kikuoka, N; Matsumoto, H; Nakatani, H; Takahashi, T; Yamane, T	1
He, G; Intengan, HD; Schiffrin, EL	1
Behl, B; Hofmann, HP; Löscher, W; Potschka, H; Szabo, L; Treiber, HJ; Wlaź, P	1
Konieczny, J; Lorenc-Koci, E; Ossowska, K; Wolfarth, S	1
Muller-Serieys, C	1
Bergogne-Bérézin, E	1
Britton, DR; Jackson, M; Jenner, P; Marsden, CD; Pearce, RK; Shiosaki, K	1
Danysz, W; Karcz-Kubicha, M; Wedzony, K; Zajaczkowski, W	1
Hidaka, H; Inoue, Y; Kimura, Y; Sudo, T; Tachibana, K; Tochizawa, S; Toga, K; Yoshida, Y	1
Bhaduri, AP; Chatterjee, RK; Chauhan, PM; Fatima, N; Srivastava, SK	1
Abely, M; de Mascarel, A; Heyman, M; Matysiak-Budnik, T; Mayo, K; Mégraud, F	1
Bubnov, VP; D'iakov, SI; Lebedeva, IK; Moskalenko, VI; Sidorenko, SV	1
Haruma, K; Kishimoto, S; Nakagawa, Y; Nakano, M; Sakurai, K; Tari, A	1
Fabian, I; Halperin, D; Kletter, Y; Nagler, A; Shalit, I; Vasserman, E; Waldman, D	1
Edelstein, MA; Edelstein, PH; Shinzato, T	1
Acosta, F; Cottagnoud, M; Cottagnoud, P; Pfister, M; Täuber, MG	1
Chen, W; He, R; Liu, X	1
He, R; Liu, X; Zhou, Z	1
Boissard, CG; Fan, W; Gribkoff, VK; Hewawasam, P; Knipe, J; Moon, SL; Starrett, JE	1
Crawley, GC; Foster, SJ; McMillan, RM; Spruce, KE; Walker, ER	1
Fujimura, J; Haruma, K; Kajiyama, G; Kishimoto, S; Kobayashi, H; Machino, H; Sakurai, K; Shimamoto, T; Shimizu, S; Yamasaki, K	1
Azoulay-Dupuis, E; Bauchet, J; Bedos, JP; Pocidalo, JJ; Vallee, E; Veber, B	1
Cohen, Y; Grosset, J; Perronne, C; Pocidalo, JJ; Truffot-Pernot, C; Vildé, JL	1
Cynamon, MH; DeStefano, MS; Klemens, SP	1
Grosset, JH; Ji, B; Perani, EG; Petinon, C	1
Aagaard, J; Madsen, PO	1
Kasatkina, IV; Makarovskaia, LN; Padeĭskaia, EN; Shcherbaniuk, AI	1
Azoulay-Dupuis, E; Bergogne-Bérézin, E; Pocidalo, JJ; Vallée, E	1
Azoulay-Dupuis, E; Bedos, JP; Pocidalo, JJ; Vallée, E	1
Azoulay-Dupuis, E; Bedos, JP; Hardy, DJ; Pocidalo, JJ; Swanson, RN; Vallée, E	1
Orr, TS	1
Rainey, DK	1
Eigyo, M; Kawasaki, K; Matsubara, K; Matsushita, A; Shindo, H; Takada, S	1
Takahashi, K	1
Coll, R; Esteve, M; Gargallo, D; Guinea, J; Moros, M; Parés, J; Xicota, MA	1

Reviews

19 review(s) available for carbostyril and Disease Models, Animal

Article	Year
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. Science & sports, 2023, Apr-04 Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide	2023
The Microbiome in Cystic Fibrosis Pulmonary Disease. Genes, 2020, 05-11, Volume: 11, Issue:5 Topics: Aminophenols; Animals; Archaea; Bacteria; Biomarkers; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Disease Progression; Dysbiosis; Fungi; Gastrointestinal Microbiome; Genotype; High-Throughput Nucleotide Sequencing; Humans; Lung; Mammals; Metagenomics; Microbiota; Organ Specificity; Prognosis; Quinolones; Viruses	2020
The Aryl Hydrocarbon Receptor: A Mediator and Potential Therapeutic Target for Ocular and Non-Ocular Neurodegenerative Diseases. International journal of molecular sciences, 2020, Sep-16, Volume: 21, Issue:18 Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Biotransformation; Central Nervous System; Cytochrome P-450 Enzyme System; Disease Models, Animal; Eye Diseases; Eye Proteins; Gene Expression Regulation; Helix-Loop-Helix Motifs; Humans; Ligands; Mammals; Molecular Targeted Therapy; Multiple Sclerosis; Nerve Degeneration; Nerve Tissue Proteins; Neurodegenerative Diseases; Parkinson Disease; Polychlorinated Dibenzodioxins; Quinolones; Rats; Receptors, Aryl Hydrocarbon; Signal Transduction; Transcription, Genetic; Xenobiotics	2020
The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections. Intensive care medicine, 2017, Volume: 43, Issue:7 Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactams; Biomarkers; Critical Illness; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Monitoring; Glycopeptides; Humans; Intensive Care Units; Quinolones; Severity of Illness Index	2017
Dopamine transporter knockdown mice in the behavioral pattern monitor: A robust, reproducible model for mania-relevant behaviors. Pharmacology, biochemistry, and behavior, 2019, Volume: 178 Topics: alpha-Methyltyrosine; Animals; Antimanic Agents; Behavior, Animal; Bipolar Disorder; Cohort Studies; Disease Models, Animal; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Enzyme Inhibitors; Exploratory Behavior; Gene Knockdown Techniques; Locomotion; Mice; Mice, Inbred C57BL; Quinolones; Reproducibility of Results; Thiophenes; Tyrosine 3-Monooxygenase; Valproic Acid	2019
T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics. Cell death & disease, 2018, 10-24, Volume: 9, Issue:11 Topics: Animals; Biomarkers, Tumor; Cell Line, Tumor; Disease Models, Animal; Drug Discovery; Humans; Indolizines; Mice; Mitogen-Activated Protein Kinase Kinases; Molecular Targeted Therapy; Neoplasms; Quinolones; Quinoxalines; Thiophenes; Treatment Outcome	2018
Useful animal models for the research of osteoarthritis. European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2014, Volume: 24, Issue:3 Topics: Animals; Anterior Cruciate Ligament; Collagenases; Disease Models, Animal; Humans; Injections, Intra-Articular; Joints; Menisci, Tibial; Osteoarthritis; Papain; Quinolones; Tibial Meniscus Injuries	2014
Use of indacaterol for the treatment of COPD: a pharmacokinetic evaluation. Expert opinion on drug metabolism & toxicology, 2014, Volume: 10, Issue:1 Topics: Animals; Bronchodilator Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Humans; Indans; Pulmonary Disease, Chronic Obstructive; Quinolones	2014
Laquinimod, an up-and-coming immunomodulatory agent for treatment of multiple sclerosis. Experimental neurology, 2014, Volume: 262 Pt A Topics: Administration, Oral; Animals; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Humans; Immunologic Factors; Multiple Sclerosis; Quinolones	2014
SAR studies on carboxylic acid series M(1) selective positive allosteric modulators (PAMs). Current topics in medicinal chemistry, 2014, Volume: 14, Issue:15 Topics: Allosteric Regulation; Allosteric Site; Alzheimer Disease; Animals; Carboxylic Acids; Cognition; Disease Models, Animal; Humans; Mice; Muscarinic Agonists; Quinolones; Receptor, Muscarinic M1; Small Molecule Libraries; Structure-Activity Relationship; Substrate Specificity	2014
Laquinimod (ABR-215062) for the treatment of relapsing multiple sclerosis. Expert review of clinical pharmacology, 2016, Volume: 9, Issue:1 Topics: Administration, Oral; Animals; Brain; Disease Models, Animal; Disease Progression; Humans; Immunologic Factors; Magnetic Resonance Imaging; Multiple Sclerosis, Relapsing-Remitting; Quinolones	2016
Laquinimod in the treatment of relapsing remitting multiple sclerosis. Expert opinion on drug metabolism & toxicology, 2016, Volume: 12, Issue:6 Topics: Administration, Oral; Animals; Disease Models, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Humans; Immunologic Factors; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neuritis, Autoimmune, Experimental; Quinolones	2016
New directions in the treatment of autism spectrum disorders from animal model research. Expert opinion on drug discovery, 2012, Volume: 7, Issue:5 Topics: Adolescent; Adolescent Behavior; Animals; Antipsychotic Agents; Aripiprazole; Brain; Central Nervous System Stimulants; Child; Child Behavior; Child Development Disorders, Pervasive; Child, Preschool; Disease Models, Animal; Dopamine Antagonists; Dopamine Uptake Inhibitors; Drug Discovery; GluK2 Kainate Receptor; Glutamic Acid; Humans; Methylphenidate; Mice; Mice, Inbred C57BL; Oxytocin; Piperazines; Quinolones; Rats; Receptors, Kainic Acid; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists	2012
Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity. Neuropharmacology, 2013, Volume: 64 Topics: Animals; Anticonvulsants; Antidepressive Agents; Aripiprazole; Behavior, Animal; Cognition; Cognition Disorders; Depression; Disease Models, Animal; Epilepsy, Absence; Nootropic Agents; Piperazines; Quinolones; Rats; Rats, Inbred Strains	2013
Chemoprevention of Helicobacter pylori-associated gastric carcinogenesis in a mouse model: is it possible? Journal of biochemistry and molecular biology, 2003, Jan-31, Volume: 36, Issue:1 Topics: Alanine; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cytokines; Disease Models, Animal; Helicobacter Infections; Helicobacter pylori; Humans; Methylnitrosourea; Mice; NF-kappa B; Quinolones; Stomach Neoplasms; Sulfonamides	2003
Schizophrenia: from dopamine to glutamate and back. Current medicinal chemistry, 2004, Volume: 11, Issue:3 Topics: Animals; Antipsychotic Agents; Aripiprazole; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Mice; Piperazines; Piperidines; Quinolones; Schizophrenia	2004
Behavioral pharmacology of sigma-ligands. Pharmacopsychiatry, 2004, Volume: 37 Suppl 3 Topics: Amnesia; Animals; Antidepressive Agents; Cinnamates; Cocaine-Related Disorders; Cyclopropanes; Disease Models, Animal; Drug Interactions; Humans; Hypericum; Ligands; Nootropic Agents; Piperazines; Plant Extracts; Psychopharmacology; Psychotic Disorders; Quinolones; Receptors, sigma; Steroids	2004
Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing. Digestive diseases and sciences, 1998, Volume: 43, Issue:9 Suppl Topics: Alanine; Animals; Anti-Ulcer Agents; Clinical Trials as Topic; Disease Models, Animal; Gastric Mucosa; Humans; Prostaglandins; Quinolones; Recurrence; Stomach Ulcer	1998
Nedocromil sodium (Tilade): a review of preclinical studies. The European respiratory journal. Supplement, 1989, Volume: 6 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Disease Models, Animal; Drug Evaluation, Preclinical; Nedocromil; Quinolones; Sheep	1989

Trials

2 trial(s) available for carbostyril and Disease Models, Animal

Article

Year

Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.

Science & sports, 2023, Apr-04

Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide

2023

Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Jul-01, Volume: 19, Issue:13

Topics: Adult; Aged; Animals; Antineoplastic Agents; Benzimidazoles; Breast Neoplasms; Cell Line, Tumor; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Fibroblast Growth Factor 3; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Gene Amplification; Humans; Mice; Middle Aged; Neoplasm Staging; Quinolones; Receptor, Fibroblast Growth Factor, Type 1; Receptor, Fibroblast Growth Factor, Type 2; Receptors, Fibroblast Growth Factor; Signal Transduction; Treatment Outcome; Xenograft Model Antitumor Assays

2013

Other Studies

285 other study(ies) available for carbostyril and Disease Models, Animal

Article	Year
Angiotensin IV attenuates diabetic cardiomyopathy Theranostics, 2021, Volume: 11, Issue:18 Topics: Angiotensin II; Animals; Apoptosis; Autophagy; Blood Glucose; Cell Line; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Disease Models, Animal; Fibrosis; Forkhead Box Protein O1; Glucose; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Oxidative Stress; Quinolones; Signal Transduction; Streptozocin; Ventricular Dysfunction, Left	2021
Strengthened rebamipide ocular nanoformulation to effectively treat corneal alkali burns in mice through the HMGB1 signaling pathway. Experimental eye research, 2021, Volume: 213 Topics: Alanine; Animals; Antioxidants; Blotting, Western; Burns, Chemical; Chickens; Chorioallantoic Membrane; Disease Models, Animal; Drug Carriers; Enzyme-Linked Immunosorbent Assay; Epithelium, Corneal; Eye Burns; Glycyrrhizic Acid; HMGB1 Protein; Humans; Mice; Ophthalmic Solutions; Quinolones; Rabbits; Signal Transduction; Sodium Hydroxide; Wound Healing	2021
Engineering a Remedy to Modulate and Optimize Biopharmaceutical Properties of Rebamipide by Synthesizing New Cocrystal: In Silico and Experimental Studies. Pharmaceutical research, 2021, Volume: 38, Issue:12 Topics: Alanine; Animals; Biological Availability; Biological Products; Carrageenan; Chemical Engineering; Chemistry, Pharmaceutical; Crystallization; Disease Models, Animal; Drug Compounding; Edema; Humans; Hydrogen Bonding; Indomethacin; Male; Powder Diffraction; Quinolones; Rats; Spectroscopy, Fourier Transform Infrared; Stomach Ulcer	2021
CAG repeat-binding small molecule improves motor coordination impairment in a mouse model of Dentatorubral-pallidoluysian atrophy. Neurobiology of disease, 2022, Volume: 163 Topics: Animals; Disease Models, Animal; Mice; Motor Skills; Myoclonic Epilepsies, Progressive; Naphthyridines; Nerve Tissue Proteins; Phenotype; Protein Aggregates; Quinolones; Trinucleotide Repeats	2022
Generation and Application of Inducible Chimeric RNA Cells, 2022, 01-14, Volume: 11, Issue:2 Topics: 4-Nitroquinoline-1-oxide; Animals; Body Weight; Carcinogens; Disease Models, Animal; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Gene Knock-In Techniques; Genotype; Mice; Mice, Inbred C57BL; Mouse Embryonic Stem Cells; Quinolones; RNA, Antisense; Tamoxifen	2022
N-Acetylcysteine and Aripiprazole Improve Social Behavior and Cognition and Modulate Brain BDNF Levels in a Rat Model of Schizophrenia. International journal of molecular sciences, 2022, Feb-15, Volume: 23, Issue:4 Topics: Acetylcysteine; Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Brain-Derived Neurotrophic Factor; Cognition; Cognition Disorders; Disease Models, Animal; Female; Hippocampus; Prefrontal Cortex; Pregnancy; Quinolones; Rats; Rats, Sprague-Dawley; Schizophrenia; Social Behavior	2022
Discovery of an Journal of medicinal chemistry, 2023, 04-27, Volume: 66, Issue:8 Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Humans; Lymphoma, Large B-Cell, Diffuse; Mice; Proto-Oncogene Proteins c-bcl-6; Quinolones; Transcription Factors	2023
Inhibition of mutant Kras and p53-driven pancreatic carcinogenesis by atorvastatin: Mainly via targeting of the farnesylated DNAJA1 in chaperoning mutant p53. Molecular carcinogenesis, 2019, Volume: 58, Issue:11 Topics: Animals; Atorvastatin; Carcinogenesis; Cell Line, Tumor; Disease Models, Animal; Farnesyltranstransferase; Gene Expression Regulation, Neoplastic; HSP40 Heat-Shock Proteins; Humans; Mice; Molecular Chaperones; Mutant Proteins; Pancreas; Pancreatic Neoplasms; Prenylation; Proto-Oncogene Proteins p21(ras); Quinolones; Tumor Suppressor Protein p53	2019
Immune modulation by rebamipide in a mouse model of Sjogren's syndrome via T and B cell regulation. Immunology letters, 2019, Volume: 214 Topics: Alanine; Animals; B-Lymphocytes, Regulatory; Cytokines; Disease Models, Animal; Immunomodulation; Mice; Oxygenases; Quinolones; Salivary Glands; Sjogren's Syndrome; Th17 Cells	2019
Brexpiprazole Reduces Survivin and Reverses EGFR Tyrosine Kinase Inhibitor Resistance in Lung and Pancreatic Cancer. Anticancer research, 2019, Volume: 39, Issue:9 Topics: Acrylamides; Aniline Compounds; Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Drug Resistance, Neoplasm; ErbB Receptors; Humans; Male; Mice; Neoplastic Stem Cells; Protein Kinase Inhibitors; Quinolones; RNA, Small Interfering; Survivin; Thiophenes; Xenograft Model Antitumor Assays	2019
Identification of the characteristic components in walnut and anti-inflammatory effect of glansreginin A as an indicator for quality evaluation. Bioscience, biotechnology, and biochemistry, 2020, Volume: 84, Issue:1 Topics: Animals; Anti-Inflammatory Agents; Behavior, Animal; Chromatography, High Pressure Liquid; Disease Models, Animal; Ellagic Acid; Hippocampus; Inflammation; Juglans; Lipopolysaccharides; Male; Methanol; Methyl Ethers; Mice; Mice, Inbred ICR; Microglia; Neuroprotective Agents; Nutritive Value; Plant Extracts; Quinolines; Quinolones	2020
FOXO1 inhibition prevents renal ischemia-reperfusion injury via cAMP-response element binding protein/PPAR-γ coactivator-1α-mediated mitochondrial biogenesis. British journal of pharmacology, 2020, Volume: 177, Issue:2 Topics: Animals; Apoptosis; Cell Line; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Forkhead Box Protein O1; Humans; Kidney Diseases; Kidney Tubules; Male; Mice, Inbred C57BL; Mitochondria; Mitophagy; Organelle Biogenesis; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Quinolones; Reperfusion Injury; Signal Transduction	2020
Graft Versus Host Disease-Associated Dry Eye: Role of Ocular Surface Mucins and the Effect of Rebamipide, a Mucin Secretagogue. Investigative ophthalmology & visual science, 2019, 11-01, Volume: 60, Issue:14 Topics: Administration, Ophthalmic; Alanine; Animals; Antioxidants; Bone Marrow Transplantation; CA-125 Antigen; Disease Models, Animal; Dry Eye Syndromes; Enzyme-Linked Immunosorbent Assay; Eye Proteins; Female; Goblet Cells; Graft vs Host Disease; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Mucin 5AC; Mucin-1; Mucin-4; Mucins; Periodic Acid-Schiff Reaction; Quinolones; Real-Time Polymerase Chain Reaction; Tears; Transplantation, Homologous	2019
Laquinimod Supports Remyelination in Non-Supportive Environments. Cells, 2019, 10-31, Volume: 8, Issue:11 Topics: Animals; Brain; Cell Differentiation; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Myelin Sheath; Oligodendrocyte Transcription Factor 2; Oligodendroglia; Quinolones; Remyelination	2019
Laquinimod ameliorates secondary brain inflammation. Neurobiology of disease, 2020, Volume: 134 Topics: Animals; Brain; Cuprizone; Disease Models, Animal; Encephalitis; Female; Gliosis; Mice, Inbred C57BL; Multiple Sclerosis; Quinolones	2020
Anti-inflammatory effects of ozenoxacin, a topical quinolone antimicrobial agent. The Journal of antibiotics, 2020, Volume: 73, Issue:4 Topics: Acne Vulgaris; Aminopyridines; Animals; Anti-Inflammatory Agents; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Inflammation; Interleukin-6; Interleukin-8; Male; Propionibacterium acnes; Quinolones; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha	2020
Synthesis, in vitro, and in vivo (Zebra fish) antitubercular activity of 7,8-dihydroquinolin-5(6H)-ylidenehydrazinecarbothioamides. Bioorganic chemistry, 2020, Volume: 96 Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Design; Humans; Hydrazines; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Quinolones; Structure-Activity Relationship; Thioamides; Tuberculosis; Zebrafish	2020
Rebamipide promotes lacrimal duct epithelial cell survival via protecting barrier function. Scientific reports, 2020, 02-03, Volume: 10, Issue:1 Topics: Alanine; Animals; Anti-Ulcer Agents; Cell Survival; Cells, Cultured; Disease Models, Animal; Electric Impedance; Epithelial Cells; Interleukin-6; Lacrimal Apparatus; Lacrimal Duct Obstruction; Male; Microscopy, Electron, Scanning; Protective Agents; Quinolones; Rabbits	2020
A slipped-CAG DNA-binding small molecule induces trinucleotide-repeat contractions in vivo. Nature genetics, 2020, Volume: 52, Issue:2 Topics: Animals; Corpus Striatum; Disease Models, Animal; DNA; DNA Mismatch Repair; DNA Replication; Humans; Huntingtin Protein; Huntington Disease; Male; Mice; Mice, Transgenic; Microsatellite Instability; Mutation; Naphthyridines; Quinolones; Ribonucleases; TATA-Box Binding Protein; Transcription, Genetic; Trinucleotide Repeat Expansion	2020
Doxorubicin induces cardiomyocyte apoptosis and atrophy through cyclin-dependent kinase 2-mediated activation of forkhead box O1. The Journal of biological chemistry, 2020, 03-27, Volume: 295, Issue:13 Topics: Animals; Apoptosis; Atrophy; Cardiotoxicity; Cyclin-Dependent Kinase 2; Disease Models, Animal; Doxorubicin; Forkhead Box Protein O1; Gene Expression Regulation; Heart; Humans; Mice; Muscle Proteins; Myocytes, Cardiac; Neoplasms; Quinolones; Signal Transduction; Tripartite Motif Proteins; Ubiquitin-Protein Ligases	2020
Levonadifloxacin, a Novel Benzoquinolizine Fluoroquinolone, Modulates Lipopolysaccharide-Induced Inflammatory Responses in Human Whole-Blood Assay and Murine Acute Lung Injury Model. Antimicrobial agents and chemotherapy, 2020, 04-21, Volume: 64, Issue:5 Topics: Acute Lung Injury; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bacteria; Cytokines; Disease Models, Animal; Humans; Immunologic Factors; Immunomodulation; Inflammation; Leukocyte Count; Lipopolysaccharides; Mice; Microbial Sensitivity Tests; Peroxidase; Quinolizines; Quinolones	2020
The farnesyltransferase inhibitor tipifarnib protects against autoimmune hepatitis induced by Concanavalin A. International immunopharmacology, 2020, Volume: 83 Topics: Animals; Antineoplastic Agents; CD4-Positive T-Lymphocytes; Cells, Cultured; Concanavalin A; Disease Models, Animal; Hepatitis, Autoimmune; Humans; Interferon-gamma; Liver; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Quinolones	2020
A PIK3CA transgenic mouse model with chemical carcinogen exposure mimics human oral tongue tumorigenesis. International journal of experimental pathology, 2020, Volume: 101, Issue:1-2 Topics: 4-Nitroquinoline-1-oxide; Animals; Cell Proliferation; Cell Transformation, Neoplastic; Class I Phosphatidylinositol 3-Kinases; Disease Models, Animal; Disease Progression; Lymphocytes; Mice, Inbred CBA; Mice, Transgenic; Mutation; Oncogene Proteins, Viral; Quinolones; Squamous Cell Carcinoma of Head and Neck; Time Factors; Tongue Neoplasms	2020
An Elvitegravir Nanoformulation Crosses the Blood-Brain Barrier and Suppresses HIV-1 Replication in Microglia. Viruses, 2020, 05-20, Volume: 12, Issue:5 Topics: Animals; Anti-HIV Agents; Anti-Retroviral Agents; Blood-Brain Barrier; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; HIV Infections; HIV-1; Integrase Inhibitors; Macrophages; Male; Mice; Mice, Inbred NOD; Microglia; Nanoparticles; Pilot Projects; Plasma; Quinolones; Viral Load; Virus Replication	2020
FOXO1 contributes to diabetic cardiomyopathy via inducing imbalanced oxidative metabolism in type 1 diabetes. Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:14 Topics: Animals; Apoptosis; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Disease Models, Animal; Disease Susceptibility; Energy Metabolism; Fatty Acids; Forkhead Box Protein O1; Gene Expression Regulation; Glucose; Glycolysis; Male; Membrane Potential, Mitochondrial; Mitochondria; Myocytes, Cardiac; Oxidation-Reduction; Oxidative Stress; Protein Transport; Quinolones; Rats; Ventricular Function, Left	2020
Brexpiprazole blocks post-traumatic stress disorder-like memory while promoting normal fear memory. Molecular psychiatry, 2021, Volume: 26, Issue:7 Topics: Animals; Disease Models, Animal; Escitalopram; Fear; Mice; Quinolones; Stress Disorders, Post-Traumatic; Thiophenes	2021
Hepatoprotective effect of rebamipide against methotrexate-induced hepatic intoxication: role of Nrf2/GSK-3β, NF-κβ-p65/JAK1/STAT3, and PUMA/Bax/Bcl-2 signaling pathways. Immunopharmacology and immunotoxicology, 2020, Volume: 42, Issue:5 Topics: Alanine; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Glycogen Synthase Kinase 3 beta; Janus Kinase 1; Liver; Male; Methotrexate; Necrosis; NF-E2-Related Factor 2; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Quinolones; Rats, Wistar; Signal Transduction; STAT3 Transcription Factor; Transcription Factor RelA	2020
Viridicatol Isolated from Deep-Sea Marine drugs, 2020, Oct-16, Volume: 18, Issue:10 Topics: Anaphylaxis; Animals; Anti-Allergic Agents; Aquatic Organisms; B-Lymphocytes; beta-N-Acetylhexosaminidases; Calcium; Cell Line, Tumor; Disease Models, Animal; Food Hypersensitivity; Histamine; Hydroxyquinolines; Immunoglobulin E; Interleukin-10; Intestines; Mast Cells; Mice; Ovalbumin; Penicillium; Peptide Hydrolases; Quinolones; Rats; T-Lymphocytes, Regulatory; Tumor Necrosis Factor-alpha	2020
Protective effect and mechanism of rebamipide on NSAIDs associated small bowel injury. International immunopharmacology, 2021, Volume: 90 Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Claudin-1; Cytokines; Diclofenac; Disease Models, Animal; Gene Expression Regulation; Humans; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Male; NF-kappa B; Quinolones; Rats, Sprague-Dawley; Signal Transduction; Toll-Like Receptor 4; Ulcer; Zonula Occludens-1 Protein	2021
Antidepressant-like activity of L-701324 in mice: A behavioral and neurobiological characterization. Behavioural brain research, 2021, 02-05, Volume: 399 Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain-Derived Neurotrophic Factor; Depression; Disease Models, Animal; Excitatory Amino Acid Antagonists; Hippocampus; Male; Mice; Mice, Inbred C57BL; Neurogenesis; Quinolones; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Stress, Psychological	2021
Antileishmanial activity of synthetic analogs of the naturally occurring quinolone alkaloid N-methyl-8-methoxyflindersin. PloS one, 2020, Volume: 15, Issue:12 Topics: Alkaloids; Animals; Antiprotozoal Agents; Cricetinae; Disease Models, Animal; Heterocyclic Compounds, 3-Ring; Humans; Leishmania guyanensis; Leishmaniasis, Cutaneous; Macrophages; Mice; Nitric Oxide; Plant Leaves; Quinolines; Quinolones; Rutaceae	2020
Whole transcriptome analysis of schinifoline treatment in Caenorhabditis elegans infected with Candida albicans. Molecular immunology, 2021, Volume: 135 Topics: Animals; Antifungal Agents; Caenorhabditis elegans; Candida albicans; Candidiasis; Disease Models, Animal; Drugs, Chinese Herbal; Fungal Proteins; Gene Expression; Gene Expression Profiling; Humans; Lysosomes; Phosphorylation; Proteins; Quinolones; Wnt Signaling Pathway	2021
Aminoalkoxycarbonyloxymethyl Ether Prodrugs with a pH-Triggered Release Mechanism: A Case Study Improving the Solubility, Bioavailability, and Efficacy of Antimalarial 4(1 Journal of medicinal chemistry, 2021, 05-27, Volume: 64, Issue:10 Topics: Administration, Oral; Animals; Antimalarials; Cyclization; Disease Models, Animal; Ethers; Female; Half-Life; Hydrogen-Ion Concentration; Malaria; Mice; Mice, Inbred BALB C; Plasmodium falciparum; Prodrugs; Quinolones; Solubility; Structure-Activity Relationship	2021
Local Anti-PD-1 Delivery Prevents Progression of Premalignant Lesions in a 4NQO-Oral Carcinogenesis Mouse Model. Cancer prevention research (Philadelphia, Pa.), 2021, Volume: 14, Issue:8 Topics: 4-Nitroquinoline-1-oxide; Animals; Antibodies, Monoclonal; Carcinogenesis; Disease Models, Animal; Drug Delivery Systems; Female; Genes, p53; Head and Neck Neoplasms; Humans; Immune Checkpoint Inhibitors; Injections, Intralesional; Male; Mice; Mice, Transgenic; Mouth Neoplasms; Precancerous Conditions; Programmed Cell Death 1 Receptor; Quinolones; Squamous Cell Carcinoma of Head and Neck	2021
A New PqsR Inverse Agonist Potentiates Tobramycin Efficacy to Eradicate Pseudomonas aeruginosa Biofilms. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2021, Volume: 8, Issue:12 Topics: Animals; Biofilms; Disease Models, Animal; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Quorum Sensing; Tobramycin	2021
Tipifarnib prevents development of hypoxia-induced pulmonary hypertension. Cardiovascular research, 2017, 03-01, Volume: 113, Issue:3 Topics: Animals; Antihypertensive Agents; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Enzyme Inhibitors; Farnesyltranstransferase; Humans; Hypertension, Pulmonary; Hypoxia; Male; Mice, Inbred C57BL; Phenotype; Protein Prenylation; Proteomics; Pulmonary Artery; Quinolones; rhoB GTP-Binding Protein; Time Factors; Transfection; Vasoconstriction; Vasodilation	2017
Laquinimod has no effects on brain volume or cellular CNS composition in the F1 3xTg-AD/C3H mouse model of Alzheimer's disease. Journal of neuroimmunology, 2017, 08-15, Volume: 309 Topics: Alzheimer Disease; Animals; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C3H; Mice, Transgenic; Organ Size; Quinolones; Treatment Outcome	2017
Restoration of CFTR Activity in Ducts Rescues Acinar Cell Function and Reduces Inflammation in Pancreatic and Salivary Glands of Mice. Gastroenterology, 2017, Volume: 153, Issue:4 Topics: Acinar Cells; Aminophenols; Animals; Aquaporin 5; Autoimmune Diseases; Bone Morphogenetic Protein 6; Calcium Signaling; Chloride Channel Agonists; Cyclopropanes; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Female; Genetic Therapy; Inositol 1,4,5-Trisphosphate Receptors; Mice, Inbred MRL lpr; Mice, Inbred NOD; ORAI1 Protein; Pancreas; Pancreatitis; Quinolones; Recovery of Function; Salivary Glands; Salivation; Sjogren's Syndrome; Time Factors; Tissue Culture Techniques; Transduction, Genetic; Up-Regulation	2017
Repurposing Ivacaftor for treatment of Staphylococcus aureus infections. International journal of antimicrobial agents, 2017, Volume: 50, Issue:3 Topics: Aminophenols; Animals; Anti-Bacterial Agents; Chloride Channel Agonists; Disease Models, Animal; Drug Repositioning; Mice, Inbred BALB C; Quinolones; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome	2017
Laquinimod treatment in the R6/2 mouse model. Scientific reports, 2017, 07-10, Volume: 7, Issue:1 Topics: Animals; Biomarkers; Body Weight; Brain-Derived Neurotrophic Factor; Cell Survival; Disease Models, Animal; Energy Metabolism; Fluorescent Antibody Technique; Gene Expression; Huntington Disease; Mice; Mice, Transgenic; Motor Activity; Neurons; PC12 Cells; Quinolones; Rats; Survival Rate	2017
Cystic Fibrosis Transmembrane Conductance Regulator Potentiation as a Therapeutic Strategy for Pulmonary Edema: A Proof-of-Concept Study in Pigs. Critical care medicine, 2017, Volume: 45, Issue:12 Topics: Administration, Inhalation; Alveolar Epithelial Cells; Aminophenols; Animals; Chloride Channel Agonists; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Prospective Studies; Pulmonary Edema; Quinolones; Swine	2017
Rebamipide alleviates radiation-induced colitis through improvement of goblet cell differentiation in mice. Journal of gastroenterology and hepatology, 2018, Volume: 33, Issue:4 Topics: Alanine; Animals; Anti-Ulcer Agents; Cell Differentiation; Cell Proliferation; Colitis; Colon; Disease Models, Animal; Epithelial Cells; Gene Expression; Goblet Cells; HT29 Cells; Humans; Male; Mice, Inbred C57BL; Mucin-2; Quinolones; Radiation Injuries, Experimental; Radiation, Ionizing; Radiotherapy	2018
Additive Effects of Rebamipide Plus Proton Pump Inhibitors on the Expression of Tight Junction Proteins in a Rat Model of Gastro-Esophageal Reflux Disease. Gut and liver, 2018, Jan-15, Volume: 12, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alanine; Animals; Anti-Ulcer Agents; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Esophageal Mucosa; Gastroesophageal Reflux; Male; Pantoprazole; Proton Pump Inhibitors; Quinolones; Rats; Rats, Sprague-Dawley; Tight Junction Proteins	2018
Inhibitors of Trypanosoma cruzi Sir2 related protein 1 as potential drugs against Chagas disease. PLoS neglected tropical diseases, 2018, Volume: 12, Issue:1 Topics: Animals; Antiprotozoal Agents; Chagas Disease; Disease Models, Animal; Enzyme Inhibitors; Mice; Niacinamide; Protozoan Proteins; Quinolones; Spermine; Treatment Outcome; Trypanosoma cruzi	2018
Laquinimod attenuates inflammation by modulating macrophage functions in traumatic brain injury mouse model. Journal of neuroinflammation, 2018, Jan-30, Volume: 15, Issue:1 Topics: Animals; Brain Injuries, Traumatic; Disease Models, Animal; Inflammation; Macrophages; Mice; Mice, Inbred C57BL; Mice, Transgenic; Quinolones	2018
[Development of "Patient Friendly Formulations" to Counter the Side Effects of Cancer Chemotherapy]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2018, Volume: 138, Issue:2 Topics: Administration, Oral; Alanine; Animals; Antineoplastic Agents; Cell Communication; Cyclic AMP; Disease Models, Animal; Drug Compounding; Evidence-Based Medicine; Gastric Mucosa; Humans; Mouthwashes; Quinolones; Stomatitis; Treatment Outcome; Triazines	2018
The Role of 2% Rebamipide Eye Drops Related to Conjunctival Differentiation in Superoxide Dismutase-1 (Sod1) Knockout Mice. Investigative ophthalmology & visual science, 2018, 03-01, Volume: 59, Issue:3 Topics: Alanine; Animals; Antioxidants; Biomarkers; Cell Differentiation; Conjunctiva; Disease Models, Animal; Dry Eye Syndromes; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Ophthalmic Solutions; Quinolones; RNA, Messenger; Superoxide Dismutase-1; Tears	2018
A review of the antibacterial activity of ozenoxacin. Future microbiology, 2018, 05-01, Volume: 13 Topics: Aminopyridines; Animals; Anti-Bacterial Agents; Child; Disease Models, Animal; Dogs; Humans; Impetigo; Quinolones; Rats; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes	2018
Therapeutic efficacy of ozenoxacin in animal models of dermal infection with Staphylococcus aureus. Future microbiology, 2018, 05-01, Volume: 13 Topics: Administration, Topical; Aminopyridines; Animals; Animals, Outbred Strains; Anti-Bacterial Agents; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Diterpenes; Dose-Response Relationship, Drug; Humans; Impetigo; Mice; Mupirocin; Ointments; Quinolones; Skin Cream; Staphylococcus aureus; Treatment Outcome; Wound Infection	2018
Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model. Journal of neuroinflammation, 2018, Jun-14, Volume: 15, Issue:1 Topics: Animals; Antigens, Differentiation; Calcium-Binding Proteins; Disease Models, Animal; Dose-Response Relationship, Drug; Electroretinography; Encephalomyelitis, Autoimmune, Experimental; Gene Expression Regulation; Mice; Mice, Inbred C57BL; Microfilament Proteins; Myelin Basic Protein; Myelin-Oligodendrocyte Glycoprotein; Nerve Tissue Proteins; Optic Nerve; Peptide Fragments; Phagocytes; Quinolones; Retina; RNA, Messenger	2018
Attenuation of murine acute lung injury by PF-573,228, an inhibitor of focal adhesion kinase. Vascular pharmacology, 2018, Volume: 110 Topics: Acute Lung Injury; Animals; Capillary Permeability; Cells, Cultured; Disease Models, Animal; Electric Impedance; Epithelial Cells; Female; Focal Adhesion Kinase 1; Lipopolysaccharides; Lung; Mice, Inbred C57BL; Phosphorylation; Protein Kinase Inhibitors; Quinolones; Signal Transduction; Sulfones; Time Factors	2018
Ivacaftor-induced sweat chloride reductions correlate with increases in airway surface liquid pH in cystic fibrosis. JCI insight, 2018, 08-09, Volume: 3, Issue:15 Topics: Adult; Aminophenols; Animals; Bicarbonates; Biological Transport, Active; Bronchoalveolar Lavage Fluid; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Female; Humans; Hydrogen-Ion Concentration; Infant; Infant, Newborn; Ion Transport; Longitudinal Studies; Lung; Male; Middle Aged; Mutation; Quinolones; Respiratory Mucosa; Sweat; Young Adult	2018
Quinolone-fused cyclic sulfonamide as a novel benign antifilarial agent. Scientific reports, 2018, 08-13, Volume: 8, Issue:1 Topics: Aedes; Animals; Apoptosis; Cattle; Disease Models, Animal; Elephantiasis, Filarial; Female; Filaricides; Humans; Male; Mice; Oxidative Stress; Parasitic Sensitivity Tests; Quinolones; Rats; RAW 264.7 Cells; Reactive Oxygen Species; Setaria Nematode; Sulfonamides; Wolbachia	2018
Comparison of Ocular Surface Mucin Expression After Topical Ophthalmic Drug Administration in Dry Eye-Induced Mouse Model. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2018, Volume: 34, Issue:9 Topics: Administration, Topical; Alanine; Animals; Anti-Inflammatory Agents; Cyclosporine; Disease Models, Animal; Dry Eye Syndromes; Epithelium, Corneal; Female; Inflammation; Mice; Mice, Inbred C57BL; Mucins; Ophthalmic Solutions; Polyphosphates; Quinolones; Uracil Nucleotides	2018
Laquinimod Treatment Improves Myelination Deficits at the Transcriptional and Ultrastructural Levels in the YAC128 Mouse Model of Huntington Disease. Molecular neurobiology, 2019, Volume: 56, Issue:6 Topics: Animals; Astrocytes; Behavior, Animal; Cell Count; Corpus Callosum; Corpus Striatum; Cytochrome P-450 CYP1A1; Depression; Disease Models, Animal; Female; Gene Expression Regulation; Humans; Huntington Disease; Inflammation; Learning; Male; Mice, Transgenic; Microglia; Motor Activity; Myelin Sheath; Oligodendroglia; Phenotype; Quinolones; Receptors, Aryl Hydrocarbon; Transcription, Genetic	2019
The Effect of Rebamipide Ophthalmic Solution on Cytokine and Mucin Secretion in Culture of Conjunctival Epithelial Cells From the Cu, Zn-Superoxide Dismutase-1 (SOD-1) Knock-Down Mouse. Eye & contact lens, 2019, Volume: 45, Issue:2 Topics: Alanine; Animals; Antioxidants; Cells, Cultured; Conjunctiva; Conjunctival Diseases; Copper; Cytokines; Disease Models, Animal; Epithelial Cells; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mucins; Ophthalmic Solutions; Quinolones; Superoxide Dismutase-1; Zinc	2019
Pharmacologic Exhaustion of Suppressor Cells with Tasquinimod Enhances Bacterial Clearance during Tuberculosis. American journal of respiratory and critical care medicine, 2019, 02-01, Volume: 199, Issue:3 Topics: Animals; Disease Models, Animal; Mice; Myeloid-Derived Suppressor Cells; Quinolones; T-Lymphocytes, Regulatory; Tuberculosis	2019
Ferulic acid potentiates the antibacterial activity of quinolone-based antibiotics against Acinetobacter baumannii. Microbial pathogenesis, 2019, Volume: 126 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adenosine Triphosphate; Animals; Anti-Bacterial Agents; Coumaric Acids; Disease Models, Animal; Drug Combinations; Drug Synergism; Electron Transport; Energy Metabolism; Glutathione; Male; Mice; Microbial Sensitivity Tests; NAD; Quinolones; Reactive Oxygen Species	2019
A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease. The EMBO journal, 2019, 01-15, Volume: 38, Issue:2 Topics: Adolescent; Aminophenols; Animals; Caco-2 Cells; Celiac Disease; Cell Line; Child; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Down-Regulation; Female; Gliadin; Humans; Male; Mice; Peptide Fragments; Protein Binding; Protein Conformation; Protein Domains; Quinolones; Young Adult	2019
Selective CB2 inverse agonist JTE907 drives T cell differentiation towards a Treg cell phenotype and ameliorates inflammation in a mouse model of inflammatory bowel disease. Pharmacological research, 2019, Volume: 141 Topics: Animals; Anti-Inflammatory Agents; Cell Differentiation; Colitis; Colon; Cytokines; Dioxoles; Disease Models, Animal; Inflammation; Inflammatory Bowel Diseases; Male; Mice, Inbred C57BL; Phenotype; Quinolones; Receptor, Cannabinoid, CB2; Spleen; T-Lymphocytes	2019
Trigeminal neuropathic pain development and maintenance in rats are suppressed by a positive modulator of α6 GABA European journal of pain (London, England), 2019, Volume: 23, Issue:5 Topics: Animals; Behavior, Animal; Disease Models, Animal; GABA-A Receptor Agonists; Male; Pyrazolones; Quinolones; Rats; Rats, Wistar; Treatment Outcome; Trigeminal Neuralgia	2019
Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer. Breast cancer research : BCR, 2019, 01-24, Volume: 21, Issue:1 Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Breast; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cohort Studies; Cytoskeletal Proteins; Disease Models, Animal; Female; Genes, Reporter; Humans; Intravital Microscopy; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mice; Mice, Inbred C57BL; Mice, Transgenic; Middle Aged; Neoplasm Recurrence, Local; Phenols; Quinolones; Tissue Array Analysis	2019
Inhibiting Sphingosine Kinase 2 Derived-sphingosine-1-phosphate Ameliorates Psoriasis-like Skin Disease via Blocking Th17 Differentiation of Naïve CD4 T Lymphocytes in Mice. Acta dermato-venereologica, 2019, May-01, Volume: 99, Issue:6 Topics: Administration, Topical; Animals; CD4-Positive T-Lymphocytes; Cell Differentiation; Ceramidases; Disease Models, Animal; Enzyme Inhibitors; Gene Expression; Imiquimod; Immunity; Inflammation; Interleukin-17; Lysophospholipids; Male; Mice; Phosphotransferases (Alcohol Group Acceptor); Psoriasis; Quinolones; RNA, Messenger; Sphingosine; Suppressor of Cytokine Signaling 1 Protein; Th17 Cells	2019
Rebamipide ophthalmic solution modulates the ratio of T helper cell 17/regulatory T cells in dry eye disease mice. Molecular medicine reports, 2019, Volume: 19, Issue:5 Topics: Alanine; Animals; Conjunctiva; Cornea; Cytokines; Disease Models, Animal; Dry Eye Syndromes; Female; Lacrimal Apparatus; Mice; Mice, Inbred C57BL; Ophthalmic Solutions; Quinolones; T-Lymphocytes, Regulatory; Th17 Cells	2019
In utero and postnatal VX-770 administration rescues multiorgan disease in a ferret model of cystic fibrosis. Science translational medicine, 2019, 03-27, Volume: 11, Issue:485 Topics: Aminophenols; Animals; Animals, Genetically Modified; Animals, Newborn; Blood Glucose; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Disease Progression; Female; Ferrets; Gene Knock-In Techniques; Genitalia, Male; Gestational Age; Humans; Male; Mutation; Pancreas, Exocrine; Pregnancy; Quinolones; Respiratory Tract Infections; Translational Research, Biomedical	2019
Rebamipide solution as a submucosal injection material for possible prevention of gastric stenosis after endoscopic submucosal dissection. Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, 2019, Volume: 31 Suppl 1 Topics: Alanine; Animals; Anti-Ulcer Agents; Disease Models, Animal; Endoscopic Mucosal Resection; Gastric Mucosa; Injections; Pyloric Stenosis; Quinolones; Swine	2019
Comparison of the Effects of Dovitinib and Bevacizumab on Reducing Neovascularization in an Experimental Rat Corneal Neovascularization Model. Cornea, 2019, Volume: 38, Issue:9 Topics: Administration, Topical; Angiogenesis Inhibitors; Animals; Benzimidazoles; Bevacizumab; Burns, Chemical; Corneal Neovascularization; Disease Models, Animal; Eye Burns; Female; Ophthalmic Solutions; Quinolones; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A	2019
The effects of antipsychotics on behavioral abnormalities of the Gunn rat (unconjugated hyperbilirubinemia rat), a rat model of schizophrenia. Asian journal of psychiatry, 2013, Volume: 6, Issue:2 Topics: Animals; Antipsychotic Agents; Aripiprazole; Disease Models, Animal; Haloperidol; Hyperbilirubinemia; Inhibition, Psychological; Locomotion; Male; Neuropsychological Tests; Piperazines; Quinolones; Rats; Rats, Gunn; Reflex, Startle; Risperidone; Schizophrenia; Social Behavior; Treatment Outcome	2013
Protection of human corneal epithelial cells from TNF-α-induced disruption of barrier function by rebamipide. Investigative ophthalmology & visual science, 2013, Apr-17, Volume: 54, Issue:4 Topics: Adherens Junctions; Alanine; Animals; Antioxidants; beta Catenin; Cadherins; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Dry Eye Syndromes; Electric Impedance; Epithelium, Corneal; Fluorescent Antibody Technique, Indirect; Humans; I-kappa B Proteins; Immunoblotting; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Occludin; Ophthalmic Solutions; Phosphorylation; Quinolones; Rats; Rats, Sprague-Dawley; Tight Junctions; Tumor Necrosis Factor-alpha; Wound Healing; Zonula Occludens-1 Protein	2013
Influence of aripiprazole and olanzapine on behavioral dysfunctions of adolescent rats exposed to stress in perinatal period. Pharmacological reports : PR, 2013, Volume: 65, Issue:1 Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Benzodiazepines; Cognition Disorders; Depression; Disease Models, Animal; Drug Administration Schedule; Female; Male; Maze Learning; Memory Disorders; Olanzapine; Piperazines; Pregnancy; Prenatal Exposure Delayed Effects; Quinolones; Rats; Rats, Wistar; Schizophrenia; Stress, Psychological; Time Factors	2013
Intervenolin, a new antitumor compound with anti-Helicobacter pylori activity, from Nocardia sp. ML96-86F2. The Journal of antibiotics, 2013, Volume: 66, Issue:9 Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Coculture Techniques; Colorectal Neoplasms; Disease Models, Animal; Female; Helicobacter pylori; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Microbial Sensitivity Tests; Nocardia; Quinolones; Stromal Cells	2013
Rebamipide suppresses PolyI:C-stimulated cytokine production in human conjunctival epithelial cells. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2013, Volume: 29, Issue:7 Topics: Alanine; Animals; Antioxidants; Conjunctiva; Conjunctivitis, Allergic; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Humans; Inflammation; Interferon Inducers; Mice; Mice, Inbred BALB C; Poly I-C; Quinolones; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger	2013
The effect of polaprezinc on gastric mucosal protection in rats with ethanol-induced gastric mucosal damage: comparison study with rebamipide. Life sciences, 2013, Jul-30, Volume: 93, Issue:2-3 Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antioxidants; Carnosine; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Gastric Mucosa; Glutathione Transferase; Heat-Shock Proteins; Heme Oxygenase-1; Male; Organometallic Compounds; Peroxiredoxins; Quinolones; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Superoxide Dismutase; Superoxide Dismutase-1; Vascular Endothelial Growth Factor A; Zinc Compounds	2013
Cis-2-dodecenoic acid signal modulates virulence of Pseudomonas aeruginosa through interference with quorum sensing systems and T3SS. BMC microbiology, 2013, Oct-18, Volume: 13 Topics: 4-Butyrolactone; Animals; Antibiosis; Bacterial Secretion Systems; Biofilms; Burkholderia cenocepacia; Disease Models, Animal; Epithelial Cells; Fatty Acids, Monounsaturated; Gene Expression Profiling; HeLa Cells; Homoserine; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Quorum Sensing; Signal Transduction; Virulence; Virulence Factors; Zebrafish	2013
K-685, a TRPV1 antagonist, blocks PKC-sensitized TRPV1 activation and improves the inflammatory pain in a rat complete Freund's adjuvant model. Journal of pharmacological sciences, 2013, Volume: 123, Issue:3 Topics: Analgesics; Animals; Chronic Pain; Disease Models, Animal; Freund's Adjuvant; Inflammation; Male; Pentanoic Acids; Protein Kinase C; Quinolones; Rats; Rats, Sprague-Dawley; TRPV Cation Channels	2013
The effects of 2% rebamipide ophthalmic solution on the tear functions and ocular surface of the superoxide dismutase-1 (sod1) knockout mice. Investigative ophthalmology & visual science, 2013, Nov-21, Volume: 54, Issue:12 Topics: Alanine; Animals; Conjunctiva; Disease Models, Animal; Dose-Response Relationship, Drug; Dry Eye Syndromes; Enzyme Inhibitors; Male; Mice; Mice, Knockout; Ophthalmic Solutions; Quinolones; Superoxide Dismutase; Superoxide Dismutase-1; Tears	2013
Changes in sensitivity of reward and motor behavior to dopaminergic, glutamatergic, and cholinergic drugs in a mouse model of fragile X syndrome. PloS one, 2013, Volume: 8, Issue:10 Topics: Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Blotting, Western; Cocaine; Disease Models, Animal; Dopamine Uptake Inhibitors; Excitatory Amino Acid Antagonists; Fragile X Mental Retardation Protein; Fragile X Syndrome; Immunoenzyme Techniques; Male; Mice; Mice, Knockout; Motor Activity; Muscarinic Antagonists; Piperazines; Pyridines; Quinolones; Receptor, Metabotropic Glutamate 5; Reward; Trihexyphenidyl; Tyrosine 3-Monooxygenase	2013
Antagonism of the adenosine A2A receptor attenuates akathisia-like behavior induced with MP-10 or aripiprazole in a novel non-human primate model. Pharmacology, biochemistry, and behavior, 2014, Volume: 118 Topics: Adenosine A2 Receptor Antagonists; Akathisia, Drug-Induced; Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Cebus; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male; Motor Activity; Phosphodiesterase Inhibitors; Piperazines; Pyrazoles; Pyrimidines; Quinolines; Quinolones; Triazoles	2014
Synthetic aminoglycosides efficiently suppress cystic fibrosis transmembrane conductance regulator nonsense mutations and are enhanced by ivacaftor. American journal of respiratory cell and molecular biology, 2014, Volume: 50, Issue:4 Topics: Aminoglycosides; Aminophenols; Animals; Biological Transport; Cell Line; Chlorides; Codon, Nonsense; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Drug Synergism; Genes, Reporter; Humans; Luciferases; Mice; Mice, Inbred CFTR; Mice, Transgenic; Organ of Corti; Quinolones; Rats; Rats, Inbred F344; Time Factors; Transfection	2014
Intravesical application of rebamipide suppresses bladder inflammation in a rat cystitis model. The Journal of urology, 2014, Volume: 191, Issue:4 Topics: Administration, Intravesical; Alanine; Animals; Cystitis; Disease Models, Animal; Female; Quinolones; Rats; Rats, Sprague-Dawley	2014
Selective action of an atypical neuroleptic on the mechanisms related to the development of cocaine addiction: a pre-clinical behavioural study. The international journal of neuropsychopharmacology, 2014, Volume: 17, Issue:4 Topics: Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Central Nervous System Sensitization; Cocaine; Cocaine-Related Disorders; Disease Models, Animal; Dopamine Antagonists; Dopamine Uptake Inhibitors; Haloperidol; Male; Mice; Motor Activity; Piperazines; Quinolones; Thiazoles	2014
Beneficial in vivo effect of aripiprazole on neuronal regeneration following neuronal loss in the dentate gyrus: evaluation using a mouse model of trimethyltin-induced neuronal loss/self-repair in the dentate gyrus. Journal of pharmacological sciences, 2014, Volume: 124, Issue:1 Topics: Animals; Aripiprazole; Bromodeoxyuridine; Cell Differentiation; Cell Proliferation; Cell Survival; Dentate Gyrus; Disease Models, Animal; Male; Mice; Mice, Inbred Strains; Nerve Regeneration; Nestin; Neural Stem Cells; Piperazines; Quinolones; Trimethyltin Compounds	2014
NMDA receptor activation antagonizes the NMDA antagonist-induced antianxiety effect in the elevated plus-maze test in mice. Pharmacological reports : PR, 2013, Volume: 65, Issue:5 Topics: 2-Amino-5-phosphonovalerate; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Binding Sites; Brain; Disease Models, Animal; Drug Interactions; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Glycine; Ligands; Male; Maze Learning; Mice; N-Methylaspartate; Quinolones; Receptors, N-Methyl-D-Aspartate; Serine	2013
Design, synthesis and evaluation of the antidepressant and anticonvulsant activities of triazole-containing quinolinones. European journal of medicinal chemistry, 2014, Feb-12, Volume: 73 Topics: Animals; Anticonvulsants; Antidepressive Agents; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Electroshock; Exploratory Behavior; Male; Mice; Mice, Inbred Strains; Molecular Structure; Quinolones; Rotarod Performance Test; Seizures; Swimming; Triazoles	2014
Laquinimod delays and suppresses nephritis in lupus-prone mice and affects both myeloid and lymphoid immune cells. Arthritis & rheumatology (Hoboken, N.J.), 2014, Volume: 66, Issue:3 Topics: Animals; Disease Models, Animal; Interferon-gamma; Interleukin-10; Interleukin-17; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphocytes; Mice; Myeloid Cells; Quinolones; Tumor Necrosis Factor-alpha	2014
Pre-treatment with the NMDA receptor glycine-binding site antagonist L-701,324 improves pharmacosensitivity in a mouse kindling model. Epilepsy research, 2014, Volume: 108, Issue:4 Topics: Animals; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Behavior, Animal; Brain; Disease Models, Animal; Drug Interactions; Excitatory Amino Acid Antagonists; Kindling, Neurologic; Male; Mice; Phenobarbital; Quinolones; Seizures	2014
Novel submicronized rebamipide liquid with moderate viscosity: significant effects on oral mucositis in animal models. Biological & pharmaceutical bulletin, 2014, Volume: 37, Issue:4 Topics: Administration, Oral; Alanine; Animals; Anti-Ulcer Agents; Cautery; Disease Models, Animal; Drug Carriers; Glossitis; Male; Nanoparticles; Oral Ulcer; Quinolones; Rats; Stomatitis; Viscosity; X-Rays	2014
Discovery of TD-4306, a long-acting β2-agonist for the treatment of asthma and COPD. Bioorganic & medicinal chemistry letters, 2014, Jul-01, Volume: 24, Issue:13 Topics: Adrenergic beta-2 Receptor Agonists; Animals; Asthma; Cell Line; Diphenylamine; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Discovery; Guinea Pigs; Humans; Molecular Structure; Pulmonary Disease, Chronic Obstructive; Quinolones; Rats; Receptors, Adrenergic, beta-2; Structure-Activity Relationship	2014
Anti-inflammatory effects of rebamipide eyedrop administration on ocular lesions in a murine model of primary Sjögren's syndrome. PloS one, 2014, Volume: 9, Issue:5 Topics: Administration, Ophthalmic; Alanine; Animals; Anti-Inflammatory Agents; Cells, Cultured; Disease Models, Animal; Drug Administration Schedule; Female; Gene Expression Regulation; Humans; Interleukin-10; Keratoconjunctivitis; Lacrimal Apparatus; Lactoferrin; Mice; Mucin 5AC; Quinolones; Sjogren's Syndrome	2014
[New therapeutic options for dry eye]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2014, Volume: 111, Issue:5 Topics: Alanine; Animals; Anti-Ulcer Agents; Cornea; Disease Models, Animal; Dry Eye Syndromes; Female; Humans; Hyaluronic Acid; Hydroxamic Acids; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Lymphocyte Function-Associated Antigen-1; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Molecular Targeted Therapy; Ophthalmic Solutions; Polyphosphates; Quinolones; Sulfonamides; Uracil Nucleotides; Viscosupplements	2014
Intravesical application of rebamipide promotes urothelial healing in a rat cystitis model. The Journal of urology, 2014, Volume: 192, Issue:6 Topics: Administration, Intravesical; Alanine; Animals; Cystitis; Disease Models, Animal; Female; Quinolones; Rats; Rats, Sprague-Dawley; Remission Induction; Urothelium	2014
Laquinimod exerts strong clinical and immunomodulatory effects in Lewis rat experimental autoimmune neuritis. Journal of neuroimmunology, 2014, Sep-15, Volume: 274, Issue:1-2 Topics: Animals; Autoimmunity; Disease Models, Animal; Female; Immunization; Immunologic Factors; Macrophages; Motor Neurons; Neural Conduction; Neuritis, Autoimmune, Experimental; Peripheral Nervous System Diseases; Quinolones; Rats; Rats, Inbred Lew; Sciatic Nerve; T-Lymphocytes	2014
Combination of omega-3 Fatty acids, lithium, and aripiprazole reduces oxidative stress in brain of mice with mania. Biological trace element research, 2014, Volume: 160, Issue:3 Topics: Animals; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Brain; Brain Chemistry; Disease Models, Animal; Fatty Acids, Omega-3; Glutathione; Lithium Compounds; Male; Mice; Oxidative Stress; Oxidoreductases; Piperazines; Quinolones	2014
Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model. Nature communications, 2014, Aug-01, Volume: 5 Topics: Action Potentials; Animals; Anticonvulsants; Disease Models, Animal; Electroencephalography; Epilepsy; Gene Expression Regulation; Heterozygote; Humans; Male; Mice; Mice, Transgenic; Microtomy; Neocortex; Patch-Clamp Techniques; Pyrazoles; Quinolones; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Tissue Culture Techniques; TOR Serine-Threonine Kinases; Tuberous Sclerosis; Tuberous Sclerosis Complex 1 Protein; Tumor Suppressor Proteins	2014
Attenuation of anhedonia by cariprazine in the chronic mild stress model of depression. Behavioural pharmacology, 2014, Volume: 25, Issue:5-6 Topics: Anhedonia; Animals; Antidepressive Agents; Aripiprazole; Chronic Disease; Depressive Disorder; Dietary Sucrose; Disease Models, Animal; Dose-Response Relationship, Drug; Drinking Behavior; Imipramine; Male; Piperazines; Quinolones; Rats, Wistar; Stress, Psychological	2014
Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases. Science translational medicine, 2014, Sep-03, Volume: 6, Issue:252 Topics: Animals; Antineoplastic Agents; Apoptosis; Benzimidazoles; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Fibroblast Growth Factor 2; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Neovascularization, Pathologic; Osteoblasts; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Quinolones; Receptor, Fibroblast Growth Factor, Type 1; Signal Transduction; Stromal Cells; Tumor Microenvironment; Xenograft Model Antitumor Assays	2014
The antipsychotic aripiprazole selectively prevents the stimulant and rewarding effects of morphine in mice. European journal of pharmacology, 2014, Nov-05, Volume: 742 Topics: Animals; Antipsychotic Agents; Aripiprazole; Central Nervous System Stimulants; Conditioning, Psychological; Disease Models, Animal; Male; Mice; Morphine; Motor Activity; Nociception; Opioid-Related Disorders; Piperazines; Quinolones; Reward	2014
Effects of multifunctional antioxidants on mitochondrial dysfunction and amyloid-β metal dyshomeostasis. Journal of Alzheimer's disease : JAD, 2015, Volume: 44, Issue:1 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Cell Line, Tumor; Disease Models, Animal; Epithelial Cells; Fluorescent Dyes; Humans; Matrix Metalloproteinase 2; Mice; Mice, Transgenic; Mitochondria; Neuroblastoma; Quinolones; Rhodamine 123; Tosyl Compounds; Zinc	2015
Pseudomonas quinolone signalling system: a component of quorum sensing cascade is a crucial player in the acute urinary tract infection caused by Pseudomonas aeruginosa. International journal of medical microbiology : IJMM, 2014, Volume: 304, Issue:8 Topics: Animals; Bacterial Load; Disease Models, Animal; DNA Transposable Elements; Female; Gene Knockout Techniques; Histocytochemistry; Kidney; Mice; Mutagenesis, Insertional; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Quorum Sensing; Severity of Illness Index; Signal Transduction; Urinary Bladder; Urinary Tract Infections; Virulence	2014
Identification of quinoline-chalcone hybrids as potential antiulcer agents. European journal of medicinal chemistry, 2015, Jan-07, Volume: 89 Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Aspirin; Chalcone; Disease Models, Animal; Dose-Response Relationship, Drug; Molecular Structure; Quinolones; Rats; Rats, Sprague-Dawley; Stomach Ulcer	2015
Remarkable progress toward new treatments for cystic fibrosis. The Lancet. Respiratory medicine, 2014, Volume: 2, Issue:12 Topics: Aminophenols; Aminopyridines; Animals; Benzodioxoles; Clinical Trials, Phase III as Topic; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Forced Expiratory Volume; Humans; Mutation; Quinolones	2014
Chemopreventive activity of systemically administered curcumin on oral cancer in the 4-nitroquinoline 1-oxide model. Journal of cellular biochemistry, 2015, Volume: 116, Issue:5 Topics: 4-Nitroquinoline-1-oxide; Animals; Antineoplastic Agents; Biomarkers, Tumor; Carcinogens; Corn Oil; Curcumin; Disease Models, Animal; Epithelial Cells; Epithelial-Mesenchymal Transition; Gene Expression; Male; Mouth Neoplasms; Quinolones; Rats; Tongue	2015
Effect of rebamipide on gastric bleeding and ulcerogenic responses induced by aspirin plus clopidogrel under stimulation of acid secretion in rats. Journal of gastroenterology and hepatology, 2014, Volume: 29 Suppl 4 Topics: Alanine; Animals; Anti-Ulcer Agents; Aspirin; Clopidogrel; Disease Models, Animal; Gastric Acid; Gastric Mucosa; Gastrointestinal Hemorrhage; Male; Platelet Aggregation Inhibitors; Quinolones; Rats, Sprague-Dawley; Stomach Ulcer; Ticlopidine; Treatment Outcome	2014
Protein kinase C inhibition rescues manic-like behaviors and hippocampal cell proliferation deficits in the sleep deprivation model of mania. The international journal of neuropsychopharmacology, 2014, Oct-31, Volume: 18, Issue:2 Topics: Animals; Antidepressive Agents, Second-Generation; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzophenanthridines; Bipolar Disorder; Cell Proliferation; Disease Models, Animal; Fluoxetine; Hippocampus; Lithium Chloride; Male; Piperazines; Prefrontal Cortex; Protein Kinase C; Protein Kinase Inhibitors; Quinolones; Rats, Sprague-Dawley; Sleep Deprivation; Tamoxifen	2014
Synthesis, radiolabeling and evaluation of novel 4-oxo-quinoline derivatives as PET tracers for imaging cannabinoid type 2 receptor. European journal of medicinal chemistry, 2015, Mar-06, Volume: 92 Topics: Adamantane; Animals; Autoradiography; Carbon Radioisotopes; Disease Models, Animal; Humans; Inflammation; Male; Mice; Molecular Imaging; Molecular Structure; Nervous System Diseases; Positron-Emission Tomography; Quinolones; Rats; Rats, Wistar; Receptor, Cannabinoid, CB2; Tissue Distribution	2015
Preventive effect of rebamipide on N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats. Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 2015, Volume: 67, Issue:3 Topics: Adenocarcinoma; Alanine; Animals; Antioxidants; Carcinogenesis; Carcinogens; Disease Models, Animal; Immunohistochemistry; Male; Methylnitronitrosoguanidine; Quinolones; Rats; Rats, Sprague-Dawley; Stomach Neoplasms	2015
Rebamipide attenuates 5-Fluorouracil-induced small intestinal mucositis in a mouse model. Biological & pharmaceutical bulletin, 2015, Volume: 38, Issue:2 Topics: Alanine; Animals; Anti-Ulcer Agents; Antimetabolites, Antineoplastic; Apoptosis; Disease Models, Animal; Fluorouracil; Glutathione; Intestine, Small; Macrophages; Male; Mice, Inbred BALB C; Mucositis; Nitric Oxide Synthase Type II; Quinolones; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha	2015
Identification of Ezrin-Radixin-Moesin proteins as novel regulators of pathogenic B-cell receptor signaling and tumor growth in diffuse large B-cell lymphoma. Leukemia, 2015, Volume: 29, Issue:9 Topics: Animals; Apoptosis; Biopsy; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; DNA-Binding Proteins; Female; Heterografts; Humans; Immunohistochemistry; Lymphoma, Large B-Cell, Diffuse; Mice; Microvilli; Phenols; Phosphorylation; Protein Binding; Protein Transport; Quinolones; Receptors, Antigen, B-Cell; Signal Transduction; Transcription Factors; Tumor Burden	2015
Rebamipide suppresses TNF-α mediated inflammation in vitro and attenuates the severity of dermatitis in mice. The FEBS journal, 2015, Volume: 282, Issue:12 Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line, Transformed; Dermatitis, Allergic Contact; Disease Models, Animal; Gene Expression Regulation; Genes, Reporter; Inflammation Mediators; Lymph Nodes; Macrophage Activation; Macrophages; Male; Mice, Inbred C57BL; NF-kappa B; Oxazolone; Quinolones; Severity of Illness Index; Signal Transduction; Skin; Tumor Necrosis Factor-alpha	2015
Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling. British journal of pharmacology, 2015, Volume: 172, Issue:14 Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Agonists; Animals; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heart Failure; Heart Rate; Indans; Male; Metoprolol; Myocardial Infarction; Quinolones; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Ventricular Remodeling	2015
Rebamipide Alters the Esophageal Microbiome and Reduces the Incidence of Barrett's Esophagus in a Rat Model. Digestive diseases and sciences, 2015, Volume: 60, Issue:9 Topics: Alanine; Animals; Anti-Ulcer Agents; Barrett Esophagus; Clostridium; Disease Models, Animal; Enterococcus; Esophagus; Lactobacillus; Male; Microbiota; Polymorphism, Restriction Fragment Length; Quinolones; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Streptococcus	2015
Effects of Long-term Blockade of Vasopressin Receptor Types 1a and 2 on Cardiac and Renal Damage in a Rat Model of Hypertensive Heart Failure. Journal of cardiovascular pharmacology, 2015, Volume: 66, Issue:5 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Disease Models, Animal; Drug Therapy, Combination; Fibrosis; Gene Expression Regulation; Heart Failure; Heart Ventricles; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Kidney; Kidney Diseases; Male; Piperidines; Quinolones; Rats, Inbred Dahl; Receptors, Vasopressin; Time Factors; Tolvaptan; Ventricular Function, Left; Ventricular Remodeling	2015
Rebamipide does not interfere with the antitumor effect of radiotherapy or chemotherapy in human oral tumor-bearing nude mice. Journal of pharmacological sciences, 2015, Volume: 129, Issue:1 Topics: Alanine; Animals; Antineoplastic Agents; Antioxidants; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Disease Models, Animal; Docetaxel; Drug Interactions; Female; Humans; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Quinolones; Radiotherapy; Stomatitis; Taxoids	2015
Rebamipide suppresses mite-induced asthmatic responses in NC/Nga mice. American journal of physiology. Lung cellular and molecular physiology, 2015, Oct-15, Volume: 309, Issue:8 Topics: 8-Hydroxy-2'-Deoxyguanosine; Alanine; Allergens; Animals; Antigens, Dermatophagoides; Antioxidants; Asthma; Bronchoalveolar Lavage Fluid; Chemokine CCL11; Chemokine CCL24; Cytokines; Deoxyguanosine; Disease Models, Animal; Interleukin-33; Lung; Macrophages; Male; Mice; Quinolones; Respiratory Hypersensitivity; RNA, Messenger	2015
SBI-0640756 Attenuates the Growth of Clinically Unresponsive Melanomas by Disrupting the eIF4F Translation Initiation Complex. Cancer research, 2015, Dec-15, Volume: 75, Issue:24 Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Eukaryotic Initiation Factor-4F; Gene Knockout Techniques; Humans; Lactams; Melanoma; Mice; Quinolones	2015
Rebamipide retards CCl4-induced hepatic fibrosis in rats: Possible role for PGE2. Journal of immunotoxicology, 2016, Volume: 13, Issue:4 Topics: Alanine; Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Carbon Tetrachloride; Collagen; Dinoprostone; Disease Models, Animal; Fibrosis; Humans; Interleukin-10; Liver; Liver Cirrhosis; Male; Oxidative Stress; Quinolones; Rats, Wistar; Up-Regulation	2016
The dynamics of gene expression changes in a mouse model of oral tumorigenesis may help refine prevention and treatment strategies in patients with oral cancer. Oncotarget, 2016, Jun-14, Volume: 7, Issue:24 Topics: 4-Nitroquinoline-1-oxide; Animals; Antineoplastic Agents; Carcinogens; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Transformation, Neoplastic; Disease Models, Animal; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Mice, Inbred CBA; Mouth Mucosa; Mouth Neoplasms; Quinolones	2016
[Evaluation of Gastric Mucosal Injury Model Animals of Rebamipide Formulation--Study of Therapeutic Equivalence]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2016, Volume: 136, Issue:4 Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Disease Models, Animal; Drug Compounding; Drugs, Generic; Gastric Mucosa; Indomethacin; Lipid Peroxides; Male; Quinolones; Rats, Wistar; Stomach Ulcer; Therapeutic Equivalency	2016
Laquinimod decreases Bax expression and reduces caspase-6 activation in neurons. Experimental neurology, 2016, Volume: 283, Issue:Pt A Topics: Animals; Antineoplastic Agents, Phytogenic; bcl-2-Associated X Protein; Camptothecin; Caspase 6; Cerebral Cortex; COS Cells; Disease Models, Animal; Dose-Response Relationship, Drug; Down Syndrome; Gene Expression Regulation; Humans; Huntingtin Protein; Mice; Mice, Transgenic; Mutation; Neurons; Protein Synthesis Inhibitors; Quinolones; Time Factors; Tosylphenylalanyl Chloromethyl Ketone	2016
SCLLTargeting FGFR1 to suppress leukemogenesis in syndromic and de novo AML in murine models. Oncotarget, 2016, Aug-02, Volume: 7, Issue:31 Topics: Animals; Benzamides; Benzimidazoles; Carcinogenesis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Gene Expression Profiling; Humans; Leukemia; Mice; Molecular Targeted Therapy; Neoplasm Transplantation; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Quinolones; Receptor, Fibroblast Growth Factor, Type 1; Xenograft Model Antitumor Assays	2016
New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections. Scientific reports, 2016, 07-14, Volume: 6 Topics: Animals; Cats; Cytochromes b; Disease Models, Animal; Drug Discovery; Drug Resistance; Feces; Humans; Oocysts; Parasite Egg Count; Plasmodium falciparum; Quinolones; Toxoplasma; Toxoplasmosis	2016
Size effect of rebamipide ophthalmic nanodispersions on its therapeutic efficacy for corneal wound healing. Experimental eye research, 2016, Volume: 151 Topics: Alanine; Animals; Antioxidants; Cell Line; Corneal Injuries; Disease Models, Animal; Epithelium, Corneal; Humans; Male; Nanoparticles; Ophthalmic Solutions; Particle Size; Quinolones; Rats; Rats, Long-Evans; Rats, Wistar; Treatment Outcome; Wound Healing	2016
PI3K/mTOR Dual Inhibitor, LY3023414, Demonstrates Potent Antitumor Efficacy Against Esophageal Adenocarcinoma in a Rat Model. Annals of surgery, 2017, Volume: 266, Issue:1 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carrier Proteins; Disease Models, Animal; Esophageal Neoplasms; Humans; Magnetic Resonance Imaging; Male; Pyridines; Quinolones; Rats, Sprague-Dawley; TOR Serine-Threonine Kinases; Tumor Burden	2017
Impact of AAC(6')-Ib-cr in combination with chromosomal-mediated mechanisms on clinical quinolone resistance in Escherichia coli. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:11 Topics: Animals; Anti-Bacterial Agents; Chromosomes, Bacterial; Ciprofloxacin; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Male; Mice, Inbred C57BL; Microbial Sensitivity Tests; Microbial Viability; Norfloxacin; Peritonitis; Plasmids; Quinolones; Sepsis; Virulence	2016
Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington disease. Scientific reports, 2016, 08-16, Volume: 6 Topics: Animals; Behavior, Animal; Corpus Striatum; Diffusion Tensor Imaging; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Huntington Disease; Interleukin-6; Male; Mice; Quinolones; White Matter	2016
The immunomodulatory effect of laquinimod in CNS autoimmunity is mediated by the aryl hydrocarbon receptor. Journal of neuroimmunology, 2016, 09-15, Volume: 298 Topics: Analysis of Variance; Animals; Axons; Brain-Derived Neurotrophic Factor; CD3 Complex; Demyelinating Autoimmune Diseases, CNS; Disease Models, Animal; Gene Expression Regulation; Immunologic Factors; Leukemic Infiltration; Mice, Inbred C57BL; Mice, Knockout; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Quinolones; Rats; Receptors, Aryl Hydrocarbon; RNA, Messenger; Spinal Cord; T-Lymphocytes; White Matter	2016
Regulatory T cells function at the early stage of tumor progression in a mouse model of tongue squamous cell carcinoma. Cancer immunology, immunotherapy : CII, 2016, Volume: 65, Issue:11 Topics: 4-Nitroquinoline-1-oxide; Animals; Carcinogenesis; Carcinoma, Squamous Cell; Cells, Cultured; Chemokine CCL17; Chemokine CCL20; Disease Models, Animal; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Humans; Interleukin-10; Lymphocyte Count; Male; Mice; Mice, Inbred C57BL; Quinolones; Receptors, CCR4; T-Lymphocytes, Regulatory; Tongue Neoplasms; Transforming Growth Factor beta	2016
Adjunctive treatment of brexpiprazole with fluoxetine shows a rapid antidepressant effect in social defeat stress model: Role of BDNF-TrkB signaling. Scientific reports, 2016, 12-19, Volume: 6 Topics: Animals; Antidepressive Agents; Azepines; Behavior, Animal; Benzamides; Brain-Derived Neurotrophic Factor; Dendritic Spines; Depressive Disorder, Major; Disease Models, Animal; Drug Therapy, Combination; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Phenotype; Quinolones; Receptor, trkB; Selective Serotonin Reuptake Inhibitors; Signal Transduction; Thiophenes	2016
CG13250, a novel bromodomain inhibitor, suppresses proliferation of multiple myeloma cells in an orthotopic mouse model. Biochemical and biophysical research communications, 2017, 03-04, Volume: 484, Issue:2 Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Enhancer Elements, Genetic; Genes, myc; Humans; Mice; Multiple Myeloma; Nuclear Proteins; Promoter Regions, Genetic; Quinolones; Survival Analysis; Transcription Factors	2017
Brexpiprazole reduces hyperactivity, impulsivity, and risk-preference behavior in mice with dopamine transporter knockdown-a model of mania. Psychopharmacology, 2017, Volume: 234, Issue:6 Topics: Animals; Behavior, Animal; Bipolar Disorder; Choice Behavior; Disease Models, Animal; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Exploratory Behavior; Female; Gene Knockdown Techniques; Impulsive Behavior; Male; Mice; Mice, Inbred C57BL; Motor Activity; Phenotype; Quinolones; Receptor, Serotonin, 5-HT1A; Risk-Taking; Serotonin Agents; Thiophenes	2017
Dysregulated Glycine Signaling Contributes to Increased Impulsivity during Protracted Alcohol Abstinence. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2017, 02-15, Volume: 37, Issue:7 Topics: Alcohol Abstinence; Alcohol Drinking; Animals; Central Nervous System Depressants; Choice Behavior; Disease Models, Animal; Ethanol; Excitatory Amino Acid Antagonists; Excitatory Amino Acid Transporter 2; Glycine; Impulsive Behavior; Male; Neurotransmitter Agents; Photic Stimulation; Quinolones; Rats; Rats, Wistar; Reaction Time; Sarcosine; Serine; Signal Transduction	2017
Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia. Psychopharmacology, 2008, Volume: 200, Issue:2 Topics: Animals; Behavior, Animal; Carrier Proteins; Clozapine; Disease Models, Animal; Glycine; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Nerve Tissue Proteins; Phenotype; Quinolones; Receptors, N-Methyl-D-Aspartate; Recognition, Psychology; Sarcosine; Schizophrenia; Schizophrenic Psychology; Serine; Social Behavior; Space Perception	2008
A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model. Proceedings of the National Academy of Sciences of the United States of America, 2008, Oct-14, Volume: 105, Issue:41 Topics: Animals; Cardiovascular Diseases; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Enzyme Inhibitors; Farnesyltranstransferase; Mice; Progeria; Quinolones	2008
Semisynthesis and antiplasmodial activity of the quinoline alkaloid aurachin E. Journal of natural products, 2008, Volume: 71, Issue:11 Topics: Alkaloids; Animals; Antimalarials; Disease Models, Animal; Mice; Mitochondria; Molecular Structure; Plasmodium berghei; Plasmodium falciparum; Quinolones; Respiration	2008
Cannabinoid-induced increase in relapse-like drinking is prevented by the blockade of the glycine-binding site of N-methyl-D-aspartate receptors. Neuroscience, 2009, Jan-23, Volume: 158, Issue:2 Topics: Alcohol Drinking; Alcoholism; Animals; Benzoxazines; Binding Sites; Cannabinoids; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Excitatory Amino Acid Antagonists; Glycine; Male; Maze Learning; Morpholines; Naphthalenes; Quinolones; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, N-Methyl-D-Aspartate; Self Administration; Substance Withdrawal Syndrome	2009
Effect of TA-270, a novel quinolinone derivative, on antigen-induced nasal blockage in a guinea pig model of allergic rhinitis. European journal of pharmacology, 2009, Jan-05, Volume: 602, Issue:1 Topics: Allergens; Animals; Antigens; Cedrus; Cinnamates; Disease Models, Animal; Dose-Response Relationship, Drug; Guinea Pigs; Leukotriene D4; Male; Nasal Obstruction; Peroxynitrous Acid; Pollen; Quinolones; Rhinitis, Allergic, Seasonal; Time Factors	2009
Discovery of inducible nitric oxide synthase (iNOS) inhibitor development candidate KD7332, part 1: Identification of a novel, potent, and selective series of quinolinone iNOS dimerization inhibitors that are orally active in rodent pain models. Journal of medicinal chemistry, 2009, May-14, Volume: 52, Issue:9 Topics: Administration, Oral; Animals; Cell Line; Constriction, Pathologic; Disease Models, Animal; Drug Discovery; Enzyme Inhibitors; Fluoroquinolones; Formaldehyde; Humans; Inhibitory Concentration 50; Lipopolysaccharides; Mice; Nitric Oxide Synthase Type II; Pain; Protein Multimerization; Protein Structure, Quaternary; Pyrazines; Quinolones; Structure-Activity Relationship; Substrate Specificity	2009
Pharmacokinetic/pharmacodynamic analysis of the influence of inoculum size on the selection of resistance in Escherichia coli by a quinolone in a mouse thigh bacterial infection model. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8 Topics: Animals; Anti-Bacterial Agents; Cyclophosphamide; Disease Models, Animal; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Polymerase Chain Reaction; Quinolones; Sequence Analysis, DNA; Thigh	2009
Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice. Psychopharmacology, 2009, Volume: 206, Issue:1 Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Disease Models, Animal; Dopamine Uptake Inhibitors; Drug Synergism; Drug Therapy, Combination; Male; Mice; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Stress, Psychological	2009
Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17. Arthritis and rheumatism, 2009, Volume: 60, Issue:8 Topics: 4-Nitroquinoline-1-oxide; Animals; Apoptosis; Autoantigens; Bone Marrow Cells; Cell Differentiation; Cell Surface Extensions; Cells, Cultured; Dendritic Cells; Disease Models, Animal; Flow Cytometry; Humans; Interleukin-17; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Microscopy, Confocal; Phagocytosis; Quinolones; T-Lymphocytes	2009
The glycine transporter-1 inhibitor SSR103800 displays a selective and specific antipsychotic-like profile in normal and transgenic mice. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2010, Volume: 35, Issue:2 Topics: Amphetamine; Analysis of Variance; Animals; Antipsychotic Agents; Aripiprazole; Catalepsy; Clozapine; Disease Models, Animal; Dizocilpine Maleate; Dopamine Plasma Membrane Transport Proteins; Glycine Plasma Membrane Transport Proteins; Hyperkinesis; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Piperazines; Quinolones; Receptors, N-Methyl-D-Aspartate	2010
Efficacy of the atypical antipsychotic aripiprazole in d-amphetamine-based preclinical models of mania. The international journal of neuropsychopharmacology, 2010, Volume: 13, Issue:4 Topics: Animals; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Central Nervous System Stimulants; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Locomotion; Male; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Self Stimulation	2010
The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior. Behavioural brain research, 2010, May-01, Volume: 209, Issue:1 Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Corticosterone; Depression; Disease Models, Animal; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Hindlimb Suspension; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Phenols; Piperazines; Quinolones; Receptors, Serotonin; Serotonin Antagonists; Sulfonamides; Swimming	2010
Potent dihydroquinolinone dopamine D2 partial agonist/serotonin reuptake inhibitors for the treatment of schizophrenia. Bioorganic & medicinal chemistry letters, 2010, May-01, Volume: 20, Issue:9 Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Dopamine Agonists; Quinolones; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship	2010
GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models. Proceedings of the National Academy of Sciences of the United States of America, 2010, Aug-24, Volume: 107, Issue:34 Topics: Allosteric Regulation; Animals; Anticonvulsants; Carbamates; Cell Line; Dipeptides; Disease Models, Animal; Electroshock; Humans; Male; Mice; Mice, Inbred C57BL; Pilocarpine; Quinolones; Rats; Rats, Wistar; Receptor, Galanin, Type 1; Receptor, Galanin, Type 2; Recombinant Proteins; Seizures; Signal Transduction; Status Epilepticus	2010
Anti-aversive effects of the atypical antipsychotic, aripiprazole, in animal models of anxiety. Journal of psychopharmacology (Oxford, England), 2011, Volume: 25, Issue:6 Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Conditioning, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Fear; Male; Maze Learning; Motor Activity; Piperazines; Quinolones; Rats; Rats, Wistar	2011
Effects of aripiprazole and haloperidol on progression to schizophrenia-like behavioural abnormalities and apoptosis in rodents. Schizophrenia research, 2011, Volume: 125, Issue:1 Topics: Acoustic Stimulation; Analysis of Variance; Animals; Antipsychotic Agents; Apoptosis; Aripiprazole; Behavioral Symptoms; Disease Models, Animal; Dizocilpine Maleate; Haloperidol; In Situ Nick-End Labeling; Inhibition, Psychological; Male; Methamphetamine; Microdialysis; Motor Activity; Neuroprotective Agents; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Reflex, Startle; Schizophrenia	2011
Delayed activation of caspase-independent apoptosis during heart failure in transgenic mice overexpressing caspase inhibitor CrmA. American journal of physiology. Heart and circulatory physiology, 2010, Volume: 299, Issue:5 Topics: 1-Naphthylamine; Animals; Apoptosis; Apoptosis Inducing Factor; Caspase Inhibitors; Caspases; Disease Models, Animal; Doxorubicin; Heart Failure; Male; Mice; Mice, Transgenic; Mitochondria, Heart; Naphthalimides; Poly(ADP-ribose) Polymerase Inhibitors; Quinolones; Serpins; Viral Proteins	2010
In vivo antibacterial activity of nemonoxacin, a novel non-fluorinated quinolone. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:11 Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Male; Mice; Microbial Sensitivity Tests; Pneumonia, Bacterial; Quinolones; Treatment Outcome; Urinary Tract Infections	2010
Luminescence targeting and imaging using a nanoscale generation 3 dendrimer in an in vivo colorectal metastatic rat model. Nanomedicine : nanotechnology, biology, and medicine, 2011, Volume: 7, Issue:3 Topics: 1-Naphthylamine; Animals; Catheterization; Cell Line, Tumor; Colorectal Neoplasms; Dendrimers; Diagnostic Imaging; Disease Models, Animal; Europium; Liver; Liver Neoplasms; Luminescence; Nanoparticles; Naphthalimides; Particle Size; Quinolones; Rats; Time Factors	2011
Dual inhibition of vascular endothelial growth factor receptor and epidermal growth factor receptor is an effective chemopreventive strategy in the mouse 4-NQO model of oral carcinogenesis. Cancer prevention research (Philadelphia, Pa.), 2010, Volume: 3, Issue:11 Topics: 4-Nitroquinoline-1-oxide; Animals; Antineoplastic Agents; Carcinogens; Disease Models, Animal; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; ErbB Receptors; Immunohistochemistry; Mice; Mice, Inbred CBA; Mouth Neoplasms; Neovascularization, Pathologic; Piperidines; Quinazolines; Quinolones; Receptors, Vascular Endothelial Growth Factor	2010
Optimization of endochin-like quinolones for antimalarial activity. Experimental parasitology, 2011, Volume: 127, Issue:2 Topics: Animals; Antimalarials; Disease Models, Animal; Drug Stability; Female; Humans; Malaria; Mice; Microsomes, Liver; Plasmodium falciparum; Plasmodium yoelii; Quinolones; Rats; Structure-Activity Relationship	2011
Effects of aripiprazole, olanzapine, and haloperidol in a model of cognitive deficit of schizophrenia in rats: relationship with glutamate release in the medial prefrontal cortex. Psychopharmacology, 2011, Volume: 214, Issue:3 Topics: Analysis of Variance; Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Benzodiazepines; Choice Behavior; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Glutamic Acid; Haloperidol; Impulsive Behavior; Male; Microdialysis; Neuropsychological Tests; Olanzapine; Piperazines; Prefrontal Cortex; Quinolones; Rats; Reaction Time; Schizophrenia; Serotonin; Time Factors	2011
Investigation of the potential utility of a linomide analogue for treatment of choroidal neovascularization. Experimental eye research, 2010, Volume: 91, Issue:6 Topics: Angiogenesis Inhibitors; Animals; Blotting, Western; Cell Proliferation; Cells, Cultured; Choroidal Neovascularization; Disease Models, Animal; Endothelium, Vascular; Fibroblast Growth Factor 2; Fluorescein Angiography; Humans; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Platelet-Derived Growth Factor; Quinolones; Rats; Rats, Inbred BN; Retinal Pigment Epithelium; Reverse Transcriptase Polymerase Chain Reaction; Umbilical Veins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2	2010
Pharmacological characterization of MRZ-8676, a novel negative allosteric modulator of subtype 5 metabotropic glutamate receptors (mGluR5): focus on L: -DOPA-induced dyskinesia. Journal of neural transmission (Vienna, Austria : 1996), 2011, Volume: 118, Issue:12 Topics: Adrenergic Agents; Allosteric Regulation; Analysis of Variance; Animals; Brain; Calcium; Cognition Disorders; Conditioning, Psychological; Disease Models, Animal; Dopamine Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Fear; In Vitro Techniques; Levodopa; Male; Maze Learning; Microdialysis; Monoamine Oxidase Inhibitors; Motor Activity; Oxidopamine; Pain Measurement; Parkinson Disease, Secondary; Picolinic Acids; Psychomotor Performance; Quinolones; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Rotarod Performance Test; Tandem Mass Spectrometry; Time Factors	2011
Optimisation of 6-substituted isoquinolin-1-amine based ROCK-I inhibitors. Bioorganic & medicinal chemistry letters, 2011, Feb-15, Volume: 21, Issue:4 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amines; Animals; Disease Models, Animal; Hypertension; Isoquinolines; Models, Chemical; Models, Molecular; Piperidines; Protein Kinase Inhibitors; Quinolones; Rats; rho-Associated Kinases; Structure-Activity Relationship	2011
Clomipramine, but not haloperidol or aripiprazole, inhibits quinpirole-induced water contrafreeloading, a putative animal model of compulsive behavior. Psychopharmacology, 2011, Volume: 218, Issue:4 Topics: Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Clomipramine; Compulsive Behavior; Conditioning, Operant; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Drinking Behavior; Haloperidol; Male; Piperazines; Quinolones; Quinpirole; Rats; Rats, Sprague-Dawley	2011
Intrathecal administration of AS1928370, a transient receptor potential vanilloid 1 antagonist, attenuates mechanical allodynia in a mouse model of neuropathic pain. Biological & pharmaceutical bulletin, 2011, Volume: 34, Issue:7 Topics: Animals; Benzamides; Capsaicin; Disease Models, Animal; Hyperalgesia; Injections, Spinal; Mice; Neuralgia; Quinolones; Tissue Distribution; TRPV Cation Channels	2011
Pre-clinical studies of a new quinolone (UB-8902) against Acinetobacter baumannii resistant to ciprofloxacin. International journal of antimicrobial agents, 2011, Volume: 38, Issue:4 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Infective Agents; Blood Bactericidal Activity; Ciprofloxacin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Lethal Dose 50; Maximum Tolerated Dose; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Molecular Conformation; Pneumonia; Quinolones	2011
Influence of aripiprazole on the antidepressant, anxiolytic and cognitive functions of rats. Pharmacological reports : PR, 2011, Volume: 63, Issue:4 Topics: Animals; Antipsychotic Agents; Anxiety; Aripiprazole; Behavior, Animal; Cognition; Depression; Disease Models, Animal; Male; Maze Learning; Memory; Piperazines; Quinolones; Rats; Rats, Wistar; Toxicity Tests	2011
Dovitinib demonstrates antitumor and antimetastatic activities in xenograft models of hepatocellular carcinoma. Journal of hepatology, 2012, Volume: 56, Issue:3 Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzimidazoles; Bevacizumab; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Division; Cell Line, Tumor; Disease Models, Animal; G2 Phase; Humans; Liver Neoplasms; Lung Neoplasms; Mice; Mice, SCID; Quinolones; Survival Rate; Xenograft Model Antitumor Assays	2012
Preliminary studies on the effect of rebamipide against the trypsin and egg-albumin induced experimental model of asthma. Acta pharmaceutica (Zagreb, Croatia), 2011, Volume: 61, Issue:4 Topics: Alanine; Animals; Asthma; Disease Models, Animal; Female; Histamine Release; Male; Mice; Ovalbumin; Quinolones; Treatment Outcome; Trypsin	2011
Apical localization of zinc transporter ZnT4 in human airway epithelial cells and its loss in a murine model of allergic airway inflammation. Nutrients, 2011, Volume: 3, Issue:11 Topics: Animals; Bronchi; Carrier Proteins; Cation Transport Proteins; Diet; Disease Models, Animal; Epithelial Cells; Fluorescent Dyes; Humans; Lung Diseases; Membrane Transport Proteins; Mice; Microscopy, Electron; Nasal Cavity; Quinolones; Rats; Reverse Transcriptase Polymerase Chain Reaction; Secretory Vesicles; Tosyl Compounds; Zinc	2011
Ivacaftor potentiation of multiple CFTR channels with gating mutations. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2012, Volume: 11, Issue:3 Topics: Aminophenols; Animals; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; DNA; DNA Mutational Analysis; Ion Channel Gating; Ion Transport; Mutation; Prognosis; Quinolones; Rats; Rats, Inbred F344; Thyroid Gland	2012
Fluoxetine and aripiprazole treatment following prenatal immune activation exert longstanding effects on rat locomotor response. Physiology & behavior, 2012, May-15, Volume: 106, Issue:2 Topics: Acute-Phase Reaction; Amphetamine; Animals; Antipsychotic Agents; Aripiprazole; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fluoxetine; Immune System; Male; Motor Activity; Piperazines; Poly I-C; Pregnancy; Prenatal Exposure Delayed Effects; Quinolones; Rats; Rats, Sprague-Dawley; Schizophrenia; Selective Serotonin Reuptake Inhibitors	2012
Highlights of the North American Cystic Fibrosis Conference 2011. Journal of the Royal Society of Medicine, 2012, Volume: 105 Suppl 2 Topics: Adolescent; Adult; Aminophenols; Animals; Anti-Bacterial Agents; Child; Child, Preschool; Congresses as Topic; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Drugs, Investigational; Female; Genetic Therapy; Humans; Infant; Infant, Newborn; Male; Mice; Mice, Transgenic; Molecular Targeted Therapy; Mutation; Neonatal Screening; Oxadiazoles; Practice Guidelines as Topic; Prognosis; Quinolones; Respiratory Function Tests; Treatment Outcome; Young Adult	2012
Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis. Journal of neuroimmunology, 2012, Oct-15, Volume: 251, Issue:1-2 Topics: Animals; Axons; Brain-Derived Neurotrophic Factor; Demyelinating Diseases; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Immunologic Factors; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Neuroprotective Agents; Quinolones; T-Lymphocytes, Regulatory	2012
Kinetics of proinflammatory monocytes in a model of multiple sclerosis and its perturbation by laquinimod. The American journal of pathology, 2012, Volume: 181, Issue:2 Topics: Animals; Cell Count; Cell Movement; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Enzyme Activation; Female; Humans; Inflammation; Kinetics; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Monocytes; Multiple Sclerosis; NF-kappa B; Quinolones; Spinal Cord	2012
A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents. American journal of respiratory and critical care medicine, 2012, Oct-01, Volume: 186, Issue:7 Topics: Animals; Benzamides; Benzimidazoles; Case-Control Studies; Crk-Associated Substrate Protein; Disease Models, Animal; Endothelial Cells; Epidermal Growth Factor; Familial Primary Pulmonary Hypertension; Fibroblast Growth Factor 2; Gefitinib; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Mice; Monocrotaline; Myocytes, Smooth Muscle; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Pulmonary Artery; Pyrimidines; Quinazolines; Quinolones; Rats; Signal Transduction	2012
Probing the modulation of acute ethanol intoxication by pharmacological manipulation of the NMDAR glycine co-agonist site. Alcoholism, clinical and experimental research, 2013, Volume: 37, Issue:2 Topics: Alcoholic Intoxication; Animals; Ataxia; Cycloserine; Disease Models, Animal; Disks Large Homolog 4 Protein; Dizocilpine Maleate; Drug Therapy, Combination; Glycine Plasma Membrane Transport Proteins; Guanylate Kinases; Hypothermia; Kynurenic Acid; Magnesium; Male; Membrane Proteins; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Quinolones; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Reflex, Righting; Sarcosine; Serine	2013
Terminal-restriction fragment length polymorphism (T-RFLP) analysis for changes in the gut microbiota profiles of indomethacin- and rebamipide-treated mice. Digestion, 2012, Volume: 86, Issue:3 Topics: Alanine; Animals; Cecum; Disease Models, Animal; DNA, Bacterial; Drug Therapy, Combination; Female; Gastrointestinal Tract; Ileum; Indomethacin; Metagenome; Mice; Mice, Inbred C57BL; Polymorphism, Restriction Fragment Length; Quinolones	2012
Inhibition of melanoma development in the Nras((Q61K)) ::Ink4a(-/-) mouse model by the small molecule BI-69A11. Pigment cell & melanoma research, 2013, Volume: 26, Issue:1 Topics: Amino Acid Substitution; Animals; Benzimidazoles; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p16; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Humans; Injections, Intraperitoneal; Ki-67 Antigen; Leukocyte Common Antigens; Melanoma; Mice; Precancerous Conditions; Proto-Oncogene Proteins B-raf; Quinolones; ras Proteins; Skin Neoplasms; Small Molecule Libraries; Xenograft Model Antitumor Assays	2013
Redundant phenazine operons in Pseudomonas aeruginosa exhibit environment-dependent expression and differential roles in pathogenicity. Proceedings of the National Academy of Sciences of the United States of America, 2012, Nov-20, Volume: 109, Issue:47 Topics: Animals; Biofilms; Colony Count, Microbial; Disease Models, Animal; Environment; Gene Expression Regulation, Bacterial; Genes, Bacterial; Lung; Mice; Mice, Inbred C57BL; Models, Biological; Operon; Phenazines; Plankton; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Virulence	2012
Effects of aripiprazole, an atypical antipsychotic, on the motor alterations induced by acute ethanol administration in mice. Basic & clinical pharmacology & toxicology, 2013, Volume: 112, Issue:5 Topics: Animals; Antipsychotic Agents; Aripiprazole; Central Nervous System Depressants; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Exploratory Behavior; Male; Mice; Motor Activity; Motor Neurons; Piperazines; Postural Balance; Quinolones; Rotarod Performance Test	2013
Clinical trials referral resource. Current clinical trials of R115777 (Zarnestra). Oncology (Williston Park, N.Y.), 2002, Volume: 16, Issue:7 Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Disease Models, Animal; Humans; Mice; Neoplasms; Quinolones; Transplantation, Heterologous	2002
Minalrestat, an aldose reductase inhibitor, corrects the impaired microvascular reactivity in diabetes. The Journal of pharmacology and experimental therapeutics, 2003, Volume: 304, Issue:3 Topics: Aldehyde Reductase; Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Drug Interactions; Galactosemias; Imides; Male; Quinolones; Rats; Rats, Wistar; Splanchnic Circulation; Vasoconstrictor Agents	2003
Reply to: Efficacy and pharmacodynamics of simulated human-like treatment with levofloxacin on experimental pneumonia induced with penicillin-resistant pneumococci with various susceptibilities to fluoroquinolones. The Journal of antimicrobial chemotherapy, 2003, Volume: 51, Issue:5 Topics: Animals; Anti-Infective Agents; Disease Models, Animal; Levofloxacin; Ofloxacin; Penicillin Resistance; Pneumonia, Pneumococcal; Quinolones; Rabbits; Streptococcus pneumoniae	2003
Pharmacodynamics of a novel des-F(6)-quinolone, BMS-284756, against Streptococcus pneumoniae in the thigh infection model. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:5 Topics: Animals; Anti-Infective Agents; Area Under Curve; Disease Models, Animal; Fluoroquinolones; Indoles; Mice; Mice, Inbred CBA; Mice, Inbred ICR; Microbial Sensitivity Tests; Pneumococcal Infections; Protein Binding; Quinolones; Streptococcus pneumoniae; Thigh	2003
Comparative assessment of prurifloxacin, sparfloxacin, gatifloxacin and levofloxacin in the rabbit model of proarrhythmia. The Journal of toxicological sciences, 2004, Volume: 29, Issue:1 Topics: Animals; Anti-Infective Agents; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Long QT Syndrome; Male; Quinolones; Rabbits; Torsades de Pointes	2004
Participation of vasopressin in the development of cerebral vasospasm in a rat model of subarachnoid haemorrhage. Clinical and experimental pharmacology & physiology, 2004, Volume: 31, Issue:4 Topics: Animals; Arginine Vasopressin; Basilar Artery; Disease Models, Animal; Female; Indoles; Pyrans; Pyrrolidines; Quinolones; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage; Vasospasm, Intracranial	2004
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a novel ATP-sensitive potassium channel opener: hemodynamic comparison to ZD-6169, WAY-133537, and nifedipine in the anesthetized canine. Journal of cardiovascular pharmacology, 2004, Volume: 44, Issue:2 Topics: Adenosine Triphosphate; Amides; Animals; Benzophenones; Blood Pressure; Cyclic S-Oxides; Cyclobutanes; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electrocardiography; Heart Rate; Hypotension; Infusions, Intravenous; Ion Channel Gating; Male; Muscle Contraction; Muscle, Smooth; Nifedipine; Nitriles; Pharmaceutical Vehicles; Polyethylene Glycols; Potassium Channels; Quinolones; Tachycardia; Urinary Bladder; Urinary Incontinence; Vascular Resistance	2004
The impact of a new immunomodulator oxo-quinoline-3-carboxamide on the progression of experimental lupus. International immunopharmacology, 2004, Volume: 4, Issue:12 Topics: Animals; Disease Models, Animal; Female; Immunity, Innate; Immunoglobulins; Immunologic Factors; Lupus Erythematosus, Systemic; Lymphocyte Activation; Male; Mice; Mice, Inbred MRL lpr; Quinolones; T-Lymphocytes; Transcription Factors	2004
[Experimental investigations of the optimal therapy of systemic BCG infection in vivo]. Aktuelle Urologie, 2004, Volume: 35, Issue:5 Topics: Adrenal Cortex Hormones; Aged; Animals; Anti-Bacterial Agents; Antitubercular Agents; BCG Vaccine; Data Interpretation, Statistical; Disease Models, Animal; Female; Humans; Hypersensitivity; Immunotherapy; Male; Mice; Mice, Inbred C57BL; Mycobacterium bovis; Quinolones; Time Factors; Tuberculosis; Tumor Cells, Cultured; Urinary Bladder; Urinary Bladder Neoplasms	2004
Suppressive effects of a selective cyclooxygenase-2 inhibitor, etodolac, on 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 2004, Volume: 56, Issue:3 Topics: 4-Nitroquinoline-1-oxide; Administration, Oral; Animals; Anticarcinogenic Agents; Carcinogens; Carcinoma, Squamous Cell; Chemoprevention; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Etodolac; Immunohistochemistry; Male; Precancerous Conditions; Quinolones; Rats; Rats, Inbred F344; Tongue; Tongue Neoplasms; Water Supply	2004
Protective effect of intra-rectal administration of rebamipide on dextran sulfate sodium-induced rat colitis. Digestion, 2004, Volume: 70, Issue:4 Topics: Administration, Rectal; Alanine; Animals; Anti-Ulcer Agents; Anticoagulants; Colitis; Dextran Sulfate; Disease Models, Animal; Male; Quinolones; Rats; Rats, Wistar	2004
Clozapine, ziprasidone and aripiprazole but not haloperidol protect against kainic acid-induced lesion of the striatum in mice, in vivo: role of 5-HT1A receptor activation. Brain research, 2005, May-10, Volume: 1043, Issue:1-2 Topics: Aminopyridines; Animals; Antipsychotic Agents; Aripiprazole; Clozapine; Corpus Striatum; Disease Models, Animal; Excitatory Amino Acid Agonists; Haloperidol; Kainic Acid; Male; Mice; Mice, Inbred C57BL; Piperazines; Piperidines; Pyridines; Quinolones; Receptor, Serotonin, 5-HT1A; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Serotonin Antagonists; Thiazoles	2005
[Comparative efficiency of treatment with moxyfloxacin and lomefloxacin for generalized murine tuberculosis caused by drug-resistant Mycobacterium strains]. Problemy tuberkuleza i boleznei legkikh, 2005, Issue:2 Topics: Animals; Antitubercular Agents; Aza Compounds; Disease Models, Animal; Drug Therapy, Combination; Fluoroquinolones; Liver; Lung; Mice; Moxifloxacin; Mycobacterium tuberculosis; Quinolines; Quinolones; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2005
Antiallodynic effects of NMDA glycine(B) antagonists in neuropathic pain: possible peripheral mechanisms. Brain research, 2005, Jun-28, Volume: 1048, Issue:1-2 Topics: Action Potentials; Animals; Constriction, Pathologic; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Kynurenic Acid; Ligation; Male; N-Methylaspartate; Neuralgia; Neurons, Afferent; Pain Measurement; Quinolones; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Nerves; Time Factors	2005
Inhibition of retinal and choroidal neovascularization by a novel KDR kinase inhibitor. Molecular vision, 2005, May-27, Volume: 11 Topics: Administration, Oral; Animals; Animals, Newborn; Choroidal Neovascularization; Chromatography, High Pressure Liquid; Disease Models, Animal; Enzyme Inhibitors; Fluorescein Angiography; Indoles; Laser Therapy; Male; Microscopy, Fluorescence; Oxygen; Quinolones; Rats; Rats, Inbred BN; Rats, Sprague-Dawley; Retinal Neovascularization; Vascular Endothelial Growth Factor Receptor-2	2005
CHIR-258: a potent inhibitor of FLT3 kinase in experimental tumor xenograft models of human acute myelogenous leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Jul-15, Volume: 11, Issue:14 Topics: Animals; Benzimidazoles; Cell Proliferation; Disease Models, Animal; DNA Mutational Analysis; Dose-Response Relationship, Drug; Female; fms-Like Tyrosine Kinase 3; Humans; Immunohistochemistry; Leukemia, Myeloid, Acute; Mice; Mice, SCID; Neoplasm Transplantation; Proto-Oncogene Proteins; Quinolones; Receptor Protein-Tyrosine Kinases; Tandem Repeat Sequences; Transplantation, Heterologous; Tumor Cells, Cultured	2005
Involvement of cannabinoid CB(2) receptor-mediated response and efficacy of cannabinoid CB(2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice. European journal of pharmacology, 2005, Sep-27, Volume: 520, Issue:1-3 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Area Under Curve; Camphanes; Cannabinoids; Dinitrofluorobenzene; Dioxoles; Disease Models, Animal; Drug Eruptions; Ear, External; Female; Indomethacin; Inflammation; Lymph Nodes; Mice; Mice, Inbred BALB C; Pyrazoles; Quinolones; Receptor, Cannabinoid, CB2; RNA, Messenger; Time Factors	2005
COX-1 and COX-2 conversely promote and suppress ischemia-reperfusion gastric injury in mice. Scandinavian journal of gastroenterology, 2005, Volume: 40, Issue:8 Topics: Alanine; Animals; Blotting, Western; Celiac Artery; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Gastric Mucosa; Intercellular Adhesion Molecule-1; Laser-Doppler Flowmetry; Ligation; Membrane Proteins; Mice; Mice, Inbred ICR; Nitrobenzenes; Peroxidase; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Quinolones; Regional Blood Flow; Reperfusion Injury; Sulfonamides; Thiobarbituric Acid Reactive Substances	2005
Direct autoradiographic evidence that rebamipide interacts with neutrophils in dextran sulfate sodium induced colitis in rats. Digestive diseases and sciences, 2005, Volume: 50 Suppl 1 Topics: Administration, Oral; Alanine; Animals; Anti-Ulcer Agents; Colitis; Dextran Sulfate; Disease Models, Animal; Goblet Cells; Indicators and Reagents; Male; Neutrophils; Quinolones; Rats; Rats, Wistar	2005
Rebamipide enema is effective for treatment of experimental dextran sulfate sodium induced colitis in rats. Digestive diseases and sciences, 2005, Volume: 50 Suppl 1 Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Enema; Indicators and Reagents; Male; Mesalamine; Quinolones; Rats; Rats, Sprague-Dawley	2005
[Antibacterial activity of a Chinese herbal medicine, Gosyuyu (Wu-Chu-Yu), against Helicobacter pylori]. Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 11 Topics: Alkaloids; Animals; Chromatography, Thin Layer; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Therapy, Combination; Drugs, Chinese Herbal; Evodia; Gastric Mucosa; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Male; Omeprazole; Plant Extracts; Quinolines; Quinolones	2005
In vivo efficacies and pharmacokinetics of DX-619, a novel des-fluoro(6) quinolone, against Streptococcus pneumoniae in a mouse lung infection model. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:1 Topics: Animals; Anti-Infective Agents; Area Under Curve; Disease Models, Animal; Lung Diseases; Mice; Mice, Inbred ICR; Pneumococcal Infections; Pyrrolidines; Quinolones; Streptococcus pneumoniae	2006
Positive interaction of the novel beta2-agonist carmoterol and tiotropium bromide in the control of airway changes induced by different challenges in guinea-pigs. Pulmonary pharmacology & therapeutics, 2007, Volume: 20, Issue:3 Topics: Acetylcholine; Adrenergic beta-2 Receptor Agonists; Airway Obstruction; Airway Resistance; Amphetamines; Animals; Bronchoconstriction; Bronchodilator Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Guinea Pigs; Histamine; Hydroxyquinolines; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Male; Ovalbumin; Quinolones; Scopolamine Derivatives; Survival Analysis; Thromboxane B2; Tiotropium Bromide; Treatment Outcome	2007
Prevention of mouse lung tumors and modulation of DNA methylation by combined treatment with budesonide and R115777 (ZarnestraMT). Carcinogenesis, 2006, Volume: 27, Issue:12 Topics: Animals; Anti-Inflammatory Agents; Budesonide; Disease Models, Animal; DNA Methylation; Drug Therapy, Combination; Female; Lung Neoplasms; Mice; Mice, Inbred A; Quinolones	2006
Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse. Biological psychiatry, 2007, Mar-01, Volume: 61, Issue:5 Topics: Animals; Antipsychotic Agents; Aripiprazole; Behavior, Addictive; Behavior, Animal; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Disease Models, Animal; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Extinction, Psychological; Male; Motor Activity; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Secondary Prevention; Self Administration	2007
The cannabinoid CB2 receptor inverse agonist JTE-907 suppresses spontaneous itch-associated responses of NC mice, a model of atopic dermatitis. European journal of pharmacology, 2006, Aug-07, Volume: 542, Issue:1-3 Topics: Administration, Oral; Animals; Behavior, Animal; Betamethasone Valerate; Body Weight; Dermatitis, Atopic; Dioxoles; Disease Models, Animal; Dose-Response Relationship, Drug; Glucocorticoids; Immunosuppressive Agents; Male; Mice; Mice, Inbred Strains; Pruritus; Quinolones; Receptor, Cannabinoid, CB2; Severity of Illness Index; Skin; Tacrolimus	2006
Behavioral and biochemical characterization of a mutant mouse strain lacking D-amino acid oxidase activity and its implications for schizophrenia. Molecular and cellular neurosciences, 2006, Volume: 32, Issue:4 Topics: Acoustic Stimulation; Animals; Brain Chemistry; Cyclic GMP; D-Amino-Acid Oxidase; Disease Models, Animal; Dose-Response Relationship, Radiation; Excitatory Amino Acid Antagonists; Extremities; Female; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Motor Activity; Neural Inhibition; Neurologic Examination; Phencyclidine; Psychomotor Performance; Quinolones; Reaction Time; Reflex, Startle; Schizophrenia; Sex Factors; Swimming	2006
Prevention of mouse lung tumors and modulation of DNA methylation by combined treatment with budesonide and R115777 (Zarnestra MT). Carcinogenesis, 2007, Volume: 28, Issue:1 Topics: Animals; Anti-Inflammatory Agents; Budesonide; Chemoprevention; Disease Models, Animal; DNA Methylation; Drug Therapy, Combination; Female; Lung Neoplasms; Mice; Mice, Inbred A; Quinolones; Urethane	2007
Potency of DX-619, a novel des-F(6)-quinolone, in haematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-intermediate Staphylococcus aureus. International journal of antimicrobial agents, 2006, Volume: 28, Issue:3 Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Lung; Male; Methicillin; Methicillin Resistance; Mice; Pneumonia, Staphylococcal; Pyrrolidines; Quinolones; Specific Pathogen-Free Organisms; Staphylococcus aureus; Vancomycin	2006
A late cutaneous response in actively sensitized rats: a new method for evaluating the efficacy of antiallergic drugs. Journal of pharmacological sciences, 2006, Volume: 101, Issue:4 Topics: Aminopyridines; Animals; Anti-Allergic Agents; Antigens; Cromolyn Sodium; Cyclosporine; Dinitrobenzenes; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Edema; Haptens; Hindlimb; Hypersensitivity, Delayed; Male; ortho-Aminobenzoates; Ovalbumin; Passive Cutaneous Anaphylaxis; Promethazine; Pyridines; Pyrimidinones; Quinolones; Rats; Rats, Wistar	2006
Effect of rebamipide on the colonic barrier in interleukin-10-deficient mice. Digestive diseases and sciences, 2007, Volume: 52, Issue:1 Topics: Alanine; Animals; Anti-Ulcer Agents; Colon; Disease Models, Animal; Female; Flow Cytometry; Helicobacter hepaticus; Helicobacter Infections; Interleukin-10; Intestinal Mucosa; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Knockout; Quinolones; Specific Pathogen-Free Organisms; T-Lymphocytes	2007
Experimental pleurodesis induced by antibiotics (macrolides or quinolones). Clinics (Sao Paulo, Brazil), 2006, Volume: 61, Issue:6 Topics: Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Macrolides; Pleural Effusion; Pleurodesis; Quinolones; Rabbits; Random Allocation; Sclerosing Solutions	2006
Novel in vivo model for the study of human immunodeficiency virus type 1 transcription inhibitors: evaluation of new 6-desfluoroquinolone derivatives. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4 Topics: Animals; Anti-HIV Agents; Cell Line; Disease Models, Animal; HIV Infections; HIV-1; Humans; Mice; Mice, SCID; Models, Biological; Quinolones	2007
Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice. European journal of pharmacology, 2007, Mar-22, Volume: 559, Issue:2-3 Topics: Animals; Animals, Newborn; Arginine Vasopressin; Atrial Natriuretic Factor; Cardiomegaly; Cell Enlargement; Cells, Cultured; Disease Models, Animal; DNA; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Immunohistochemistry; Male; Mice; Mice, Knockout; Myocytes, Cardiac; Phosphorylation; Piperidines; Protein Biosynthesis; Quinolones; Receptors, Vasopressin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Transcription, Genetic; Vasoconstrictor Agents	2007
Differential effects of phosphodiesterase PDE-3/PDE-4-specific inhibitors on vasoconstriction and cAMP-dependent vasorelaxation following balloon angioplasty. American journal of physiology. Heart and circulatory physiology, 2007, Volume: 292, Issue:6 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Angioplasty, Balloon; Animals; Aorta; Carboxylic Acids; Cilostazol; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Male; Milrinone; Nitriles; Phosphodiesterase Inhibitors; Phosphorylation; Quinolones; Rats; Rats, Sprague-Dawley; Tetrazoles; Up-Regulation; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents	2007
Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2007, Volume: 32, Issue:10 Topics: Amphetamine-Related Disorders; Animals; Antipsychotic Agents; Aripiprazole; Brain; Brain Chemistry; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Drug Administration Schedule; Drug Interactions; Male; Methamphetamine; Nucleus Accumbens; Piperazines; Quinolones; Rats; Rats, Wistar; Receptors, Dopamine D2; Self Administration	2007
Expression of receptor for advanced glycation end products during rat tongue carcinogenesis by 4-nitroquinoline 1-oxide and effect of a selective cyclooxygenase-2 inhibitor, etodolac. Pathobiology : journal of immunopathology, molecular and cellular biology, 2006, Volume: 73, Issue:6 Topics: 4-Nitroquinoline-1-oxide; Animals; Anticarcinogenic Agents; Cell Transformation, Neoplastic; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Etodolac; Gene Expression Regulation, Neoplastic; Immunohistochemistry; Male; Quinolones; Rats; Rats, Inbred F344; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tongue; Tongue Neoplasms	2006
Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes. Journal of cardiovascular electrophysiology, 2007, Volume: 18, Issue:6 Topics: Action Potentials; Animals; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiologic Techniques, Cardiac; Fluoroquinolones; Heart Conduction System; In Vitro Techniques; Levofloxacin; Male; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Rabbits; Torsades de Pointes	2007
Dihydro-[1H]-quinolin-2-ones as retinoid X receptor (RXR) agonists for potential treatment of dyslipidemia. Bioorganic & medicinal chemistry letters, 2007, Jun-15, Volume: 17, Issue:12 Topics: Animals; Diabetes Mellitus; Disease Models, Animal; Dyslipidemias; Hypoglycemic Agents; Quinolones; Rats; Rats, Sprague-Dawley; Retinoid X Receptors; Structure-Activity Relationship	2007
An assessment of the in vivo efficacy of the glycogen phosphorylase inhibitor GPi688 in rat models of hyperglycaemia. British journal of pharmacology, 2007, Volume: 152, Issue:8 Topics: Animals; Blood Glucose; Disease Models, Animal; Dose-Response Relationship, Drug; Glucagon; Glucose; Glucose Tolerance Test; Glycogen Phosphorylase; Glycogen Synthase; Hepatocytes; Hyperglycemia; Inhibitory Concentration 50; Male; Obesity; Quinolones; Rats; Rats, Wistar; Rats, Zucker; Thiophenes	2007
Treatment of Pseudomonas aeruginosa biofilms with a combination of fluoroquinolones and fosfomycin in a rat urinary tract infection model. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2007, Volume: 13, Issue:5 Topics: Animals; Anti-Bacterial Agents; Biofilms; Catheters, Indwelling; Dioxolanes; Disease Models, Animal; Drug Therapy, Combination; Female; Fluoroquinolones; Fosfomycin; Humans; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Piperazines; Polyethylene; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Rats; Urinary Catheterization; Urinary Tract Infections	2007
Effects of EDP-420 on penicillin-resistant and quinolone- and penicillin-resistant pneumococci in the rabbit meningitis model. The Journal of antimicrobial chemotherapy, 2008, Volume: 61, Issue:3 Topics: Animals; Bridged-Ring Compounds; Disease Models, Animal; Macrolides; Meningitis, Bacterial; Penicillin Resistance; Penicillins; Quinolones; Rabbits; Streptococcus pneumoniae	2008
Effective treatment with oral administration of rebamipide in a mouse model of Sjögren's syndrome. Arthritis and rheumatism, 2008, Volume: 58, Issue:2 Topics: Administration, Oral; Alanine; Animals; Anti-Inflammatory Agents; Autoantibodies; Cell Division; Cytokines; Disease Models, Animal; Female; Immunologic Factors; Lacrimal Apparatus; Mice; Mice, Mutant Strains; Quinolones; Salivary Glands; Sjogren's Syndrome; T-Lymphocytes; Thymectomy	2008
Intraocular pharmacokinetics of intravenously administered marbofloxacin in rabbits with experimentally induced acute endophthalmitis. American journal of veterinary research, 2008, Volume: 69, Issue:3 Topics: Animals; Anti-Infective Agents; Aqueous Humor; Area Under Curve; Disease Models, Animal; Dog Diseases; Dogs; Endophthalmitis; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Half-Life; Injections, Intravenous; Male; Quinolones; Rabbits; Vitreous Body	2008
Vulnerability of gastric mucosa to prednisolone in rats chronically exposed to cigarette smoke. Journal of pharmacological sciences, 2008, Volume: 106, Issue:4 Topics: Alanine; Animals; Anti-Ulcer Agents; Blood Gas Analysis; Dinoprostone; Disease Models, Animal; Gastric Mucosa; Hypoxia-Inducible Factor 1, alpha Subunit; Lipid Peroxides; Male; Peptic Ulcer Hemorrhage; Prednisolone; Pulmonary Disease, Chronic Obstructive; Quinolones; Rats; Rats, Wistar; Respiratory Function Tests; Respiratory System; Smoking; Stomach Ulcer; Vascular Endothelial Growth Factor A	2008
Model mice for mild-form glycine encephalopathy: behavioral and biochemical characterizations and efficacy of antagonists for the glycine binding site of N-methyl D-aspartate receptor. Pediatric research, 2008, Volume: 64, Issue:3 Topics: Aggression; Amino Acid Oxidoreductases; Animals; Anxiety; Binding Sites; Brain Diseases, Metabolic; Carrier Proteins; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glycine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Multienzyme Complexes; Pyrrolidinones; Quinolones; Receptors, N-Methyl-D-Aspartate; Seizures; Transferases	2008
Effect of vasopressin V1- and V2-receptor stimulation on blood pressure in DOCA-salt hypertensive rats. Acta medica Okayama, 1995, Volume: 49, Issue:4 Topics: Animals; Benzazepines; Blood Pressure; Desoxycorticosterone; Disease Models, Animal; Heart Rate; Male; Piperidines; Quinolones; Rats; Rats, Inbred SHR; Rats, Wistar; Receptors, Vasopressin; Time Factors	1995
Effects of novel, nonpeptide vasopressin antagonists on progressive nephrosclerosis in rats. Journal of cardiovascular pharmacology, 1995, Volume: 25, Issue:5 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Blood Pressure; Body Weight; Disease Models, Animal; Diuresis; Glomerulosclerosis, Focal Segmental; Hypertension; Kidney; Male; Nephrectomy; Nephrosclerosis; Piperidines; Proteinuria; Quinolones; Rats; Rats, Inbred SHR	1995
In-vitro and in-vivo activity of a new quinolone AM-1155 against Mycoplasma pneumoniae. The Journal of antimicrobial chemotherapy, 1994, Volume: 34, Issue:6 Topics: Animals; Anti-Infective Agents; Cell Death; Cricetinae; Disease Models, Animal; Erythromycin; Fluoroquinolones; Gatifloxacin; Lung; Male; Mesocricetus; Minocycline; Mycoplasma pneumoniae; Piperazines; Pneumonia, Mycoplasma; Quinolones	1994
[Comparative evaluation of the effectiveness of fluoroquinolones in experimental anthrax infection]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1994, Volume: 39, Issue:6 Topics: Animals; Anthrax; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Drug Evaluation, Preclinical; Evaluation Studies as Topic; Fluoroquinolones; Lethal Dose 50; Mice; Microbial Sensitivity Tests; Pefloxacin; Quinolones	1994
Activity of levofloxacin in a murine model of tuberculosis. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:7 Topics: Animals; Antitubercular Agents; Culture Media; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Levofloxacin; Lung; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Quinolones; Spleen; Stereoisomerism; Tuberculosis, Pulmonary	1994
Effects of OPC-18790, a new positive inotropic agent, on canine ventricular arrhythmias. Japanese journal of pharmacology, 1993, Volume: 63, Issue:3 Topics: Animals; Blood Pressure; Cardiotonic Agents; Coronary Circulation; Disease Models, Animal; Dogs; Epinephrine; Female; Heart Rate; Male; Myocardial Contraction; Myocardial Ischemia; Ouabain; Quinolones; Tachycardia, Ventricular; Vasodilation; Ventricular Fibrillation	1993
Activity of sparfloxacin against Mycobacterium leprae measured by the proportional bactericidal test. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1993, Volume: 61, Issue:4 Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Colony Count, Microbial; Disease Models, Animal; Fluoroquinolones; Leprosy; Mice; Mice, Nude; Microbial Sensitivity Tests; Mycobacterium leprae; Ofloxacin; Quinolones	1993
Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:8 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cefpirome; Ceftriaxone; Cephalosporins; Disease Models, Animal; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Male; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Rabbits; Rifampin; Thienamycins; Vancomycin	1993
Effect of nedocromil sodium on specific mediator- and antigen-induced airway responses in allergic sheep. The Journal of allergy and clinical immunology, 1993, Volume: 92, Issue:1 Pt 2 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Helminth; Ascaris; Bradykinin; Bronchi; Bronchial Hyperreactivity; Bronchoconstriction; Disease Models, Animal; Drug Evaluation, Preclinical; Nedocromil; Platelet Activating Factor; Quinolones; Respiratory Hypersensitivity; Sheep; Time Factors	1993
Nedocromil sodium blocks the early and late phases of allergen challenge in a guinea pig model of asthma. The Journal of allergy and clinical immunology, 1993, Volume: 92, Issue:1 Pt 2 Topics: Aerosols; Albuterol; Allergens; Animals; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Bronchoalveolar Lavage Fluid; Depression, Chemical; Disease Models, Animal; Drug Evaluation, Preclinical; Eosinophils; Guinea Pigs; Nedocromil; Neutrophils; Quinolones; Time Factors	1993
Evaluation of 5-lipoxygenase inhibitors, zileuton, A-78773 and ICI-D-2138 in an ionophore (A-23187)-induced pleural inflammation model in the rat. Life sciences, 1993, Volume: 53, Issue:9 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcimycin; Disease Models, Animal; Drug Evaluation, Preclinical; Eicosanoids; Hydroxyurea; Leukotrienes; Lipoxygenase Inhibitors; Male; Pleurisy; Prostaglandins; Pyrans; Quinolones; Rats; Rats, Sprague-Dawley	1993
Therapeutic efficacy of some new quinolones and a combination of ofloxacin with rifampin against Mycobacterium leprae infection induced in athymic nude mice. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1993, Volume: 61, Issue:2 Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Female; Leprosy; Mice; Mice, Inbred BALB C; Mice, Nude; Ofloxacin; Quinolones; Rifampin	1993
ABT-431: the diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's disease. The Journal of pharmacology and experimental therapeutics, 1996, Volume: 276, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Behavior, Animal; Callithrix; CHO Cells; Corpus Striatum; Cricetinae; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Fishes; Humans; Kinetics; Male; Mice; Parkinson Disease, Secondary; Prodrugs; Pyridines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Tetrahydronaphthalenes; Thiophenes	1996
Quinolone arthropathy in immature rabbits treated with the fluoroquinolone, PD 117596. Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 1996, Volume: 48, Issue:4 Topics: Animals; Anti-Infective Agents; Arthritis; Cartilage, Articular; Disease Models, Animal; Fluoroquinolones; Knee Joint; Magnetic Resonance Imaging; Male; Quinolones; Rabbits	1996
Impairment of antioxidants in colonic epithelial cells isolated from trinitrobenzene sulphonic acid-induced colitis rats. Protective effect of rebamipide. Scandinavian journal of gastroenterology, 1996, Volume: 31, Issue:10 Topics: Alanine; Analysis of Variance; Animals; Anti-Ulcer Agents; Antioxidants; Colitis; Culture Techniques; Disease Models, Animal; Glutathione; Glutathione Peroxidase; Glutathione Transferase; Intestinal Mucosa; Male; Quinolones; Random Allocation; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid	1996
Predicting injection site muscle damage. II: Evaluation of extended release parenteral formulations in animal models. Pharmaceutical research, 1996, Volume: 13, Issue:10 Topics: Animals; Anti-Infective Agents; Chemistry, Pharmaceutical; Creatine Kinase; Delayed-Action Preparations; Disease Models, Animal; Drug Evaluation, Preclinical; Edema; Evaluation Studies as Topic; Fluoroquinolones; Injections, Intramuscular; Muscles; Predictive Value of Tests; Quinolones; Rabbits; Rats	1996
Predicting injection site muscle damage. III: Evaluation of intramuscular formulations in the L6 cell model. Pharmaceutical research, 1996, Volume: 13, Issue:10 Topics: Animals; Anti-Infective Agents; Azithromycin; Cells, Cultured; Chemistry, Pharmaceutical; Creatine Kinase; Digoxin; Disease Models, Animal; Drug Evaluation, Preclinical; Edema; Evaluation Studies as Topic; Fluoroquinolones; Injections, Intramuscular; Muscle, Skeletal; Predictive Value of Tests; Quinolones; Rabbits; Rats	1996
Effects of rebamipide on bile acid-induced inhibition of gastric epithelial repair in a rabbit cell culture model. Alimentary pharmacology & therapeutics, 1996, Volume: 10, Issue:6 Topics: Actins; Alanine; Animals; Anti-Ulcer Agents; Bromodeoxyuridine; Cell Division; Cell Movement; Cells, Cultured; Deoxycholic Acid; Disease Models, Animal; Epithelial Cells; Epithelium; Gastric Mucosa; Male; Quinolones; Rabbits; Staining and Labeling; Stomach Diseases	1996
[Antitubercular activity of lomefloxacin in an experiment]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1996, Volume: 41, Issue:7-8 Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fluoroquinolones; Isoniazid; Lung; Mice; Mycobacterium tuberculosis; Quinolones; Reference Values; Spleen; Survival Rate; Tuberculosis	1996
Pharmacodynamics and pharmacokinetics of A-80556 using microdialysis in a Streptococcus pneumoniae meningitis model. The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:6 Topics: Animals; Anti-Infective Agents; Disease Models, Animal; Fluoroquinolones; Meningitis, Bacterial; Microbial Sensitivity Tests; Microdialysis; Pneumococcal Infections; Quinolones; Rabbits; Streptococcus pneumoniae	1996
Effect of 6-fluoro-8-methoxy quinolone (AM-1155) against chronic airway infection with Pseudomonas aeruginosa in a rat model. The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:2 Topics: Animals; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Fluoroquinolones; Gatifloxacin; Immunoglobulin A; Immunoglobulin G; Male; Piperazines; Pseudomonas Infections; Quinolones; Rats; Rats, Sprague-Dawley; Tracheal Diseases	1997
In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:6 Topics: Animals; Anti-Infective Agents; Chlamydia; Chlamydia Infections; Chlamydia trachomatis; Chlamydophila pneumoniae; Chlamydophila psittaci; Disease Models, Animal; Fluoroquinolones; Gatifloxacin; Male; Mice; Microbial Sensitivity Tests; Piperazines; Pneumonia, Bacterial; Quinolones	1997
[A chronobiological study of the function of the epithelial proliferative system of the murine esophagus after its infection with typhoid and the use of lomefloxacin]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1996, Volume: 41, Issue:11 Topics: Animals; Anti-Infective Agents; Cell Division; Chronobiology Phenomena; Disease Models, Animal; Drug Evaluation, Preclinical; Epithelium; Esophageal Diseases; Esophagus; Fluoroquinolones; Male; Mice; Mitotic Index; Quinolones; Time Factors; Typhoid Fever	1996
Therapeutic effects of a new quinolone, DU-6859a, on polymicrobial infections in a newly designed model of rat uterine endometritis. The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:1 Topics: Animals; Anti-Infective Agents; Bacteroides fragilis; Disease Models, Animal; Drug Therapy, Combination; Endometritis; Escherichia coli; Female; Fluoroquinolones; Levofloxacin; Ofloxacin; Quinolones; Rats; Rats, Sprague-Dawley	1998
Comparative therapeutic efficacy of clinafloxacin in a Pseudomonas aeruginosa mouse renal abscess model. The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:3 Topics: Abscess; Animals; Anti-Infective Agents; Area Under Curve; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Fluoroquinolones; Half-Life; Imipenem; Kidney; Kidney Diseases; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Treatment Outcome	1998
Moxifloxacin in the therapy of experimental pneumococcal meningitis. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:6 Topics: Animals; Anti-Infective Agents; Aza Compounds; Colony Count, Microbial; Disease Models, Animal; Fluoroquinolones; Meningitis, Pneumococcal; Moxifloxacin; Pneumococcal Infections; Quinolines; Quinolones; Rabbits; Streptococcus pneumoniae	1998
Acute effects of toborinone on vascular capacitance and conductance in experimental heart failure. Circulation, 1998, Jul-07, Volume: 98, Issue:1 Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Dogs; Enalaprilat; Female; Heart Failure; Hemodynamics; Hydralazine; Male; Nitroglycerin; Phosphodiesterase Inhibitors; Quinolones; Vascular Capacitance; Vasodilator Agents	1998
Bacterial eradication by clinafloxacin, CI-990, and ciprofloxacin employing MBC test, in-vitro time-kill and in-vivo time-kill studies. The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:6 Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Naphthyridines; Quinolones	1998
Rebamipide treatment activates epidermal growth factor and its receptor expression in normal and ulcerated gastric mucosa in rats: one mechanism for its ulcer healing action? Digestive diseases and sciences, 1998, Volume: 43, Issue:9 Suppl Topics: Alanine; Animals; Anti-Ulcer Agents; Disease Models, Animal; Epidermal Growth Factor; ErbB Receptors; Fluorescent Antibody Technique; Gene Expression Regulation; Male; Quinolones; Rats; Rats, Sprague-Dawley; Stomach Ulcer	1998
Effect of rebamipide on liver damage and increased tumor necrosis factor in a rat model of endotoxin shock. Digestive diseases and sciences, 1998, Volume: 43, Issue:9 Suppl Topics: Alanine; Animals; Disease Models, Animal; Enzyme Inhibitors; Escherichia coli; Lipopolysaccharides; Liver; Male; Peroxidase; Quinolones; Rats; Rats, Sprague-Dawley; Shock, Septic; Tumor Necrosis Factor-alpha	1998
Inhibitory effects of rebamipide on ENNG-induced duodenal carcinogenesis in mice: a possible strategy for chemoprevention of gastrointestinal cancers. Digestive diseases and sciences, 1998, Volume: 43, Issue:9 Suppl Topics: Alanine; Animals; Antineoplastic Agents; Carcinogens; Disease Models, Animal; Dose-Response Relationship, Drug; Duodenal Neoplasms; Male; Methylnitronitrosoguanidine; Mice; Mice, Inbred C57BL; Quinolones	1998
Effect of vasopressin antagonism on structure and mechanics of small arteries and vascular expression of endothelin-1 in deoxycorticosterone acetate salt hypertensive rats. Hypertension (Dallas, Tex. : 1979), 1998, Volume: 32, Issue:4 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Biomechanical Phenomena; Blood Pressure; Desoxycorticosterone; Disease Models, Animal; Elasticity; Endothelin-1; Gene Expression; Hypertension; Male; Mesenteric Artery, Superior; Nephrectomy; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Vasodilation	1998
LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy. British journal of pharmacology, 1998, Volume: 125, Issue:6 Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anticonvulsants; Disease Models, Animal; Dizocilpine Maleate; Drug Synergism; Epilepsy; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Imidazoles; Kindling, Neurologic; Male; Mice; Mice, Inbred Strains; N-Methylaspartate; Quinolones; Quinoxalines; Receptors, AMPA; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Tritium	1998
The role of striatal glutamate receptors in models of Parkinson's disease. Amino acids, 1998, Volume: 14, Issue:1-3 Topics: Animals; Corpus Striatum; Disease Models, Animal; Dizocilpine Maleate; Electromyography; Excitatory Amino Acid Antagonists; Haloperidol; Kynurenic Acid; Parkinson Disease; Quinolones; Rats; Receptors, N-Methyl-D-Aspartate; Reserpine	1998
[Bacterial resistance and new therapeutic perspectives]. Presse medicale (Paris, France : 1983), 1998, Volume: 27 Suppl 5 Topics: Animals; Anti-Infective Agents; Disease Models, Animal; Drug Resistance, Microbial; Erythromycin; Fluoroquinolones; Humans; In Vitro Techniques; Macrolides; Quinolones; Staphylococcus aureus; Streptococcus pneumoniae	1998
[New developments in pharmacology of antibiotics]. Presse medicale (Paris, France : 1983), 1998, Volume: 27 Suppl 5 Topics: Animals; Anti-Infective Agents; Aza Compounds; Disease Models, Animal; Drug Resistance, Microbial; Fluoroquinolones; Humans; In Vitro Techniques; Meropenem; Moxifloxacin; Quinolines; Quinolones; Thienamycins	1998
Actions of the D1 agonists A-77636 and A-86929 on locomotion and dyskinesia in MPTP-treated L-dopa-primed common marmosets. Psychopharmacology, 1999, Volume: 142, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adamantane; Animals; Benzopyrans; Callithrix; Disease Models, Animal; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Levodopa; Locomotion; Male; Quinolones; Receptors, Dopamine D1; Thiophenes	1999
NMDA receptor antagonists acting at the glycineB site in rat models for antipsychotic-like activity. Journal of neural transmission (Vienna, Austria : 1996), 1999, Volume: 106, Issue:11-12 Topics: 2-Amino-5-phosphonovalerate; Amphetamine; Animals; Antimetabolites; Antipsychotic Agents; Binding Sites; Cycloleucine; Cycloserine; Disease Models, Animal; Dopamine Agents; Drug Synergism; Excitatory Amino Acid Antagonists; Glycine; Hallucinogens; Locomotion; Male; Phencyclidine; Phthalazines; Protein Structure, Tertiary; Psychotic Disorders; Pyrrolidinones; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Reflex, Startle	1999
Suppression of arterial intimal hyperplasia by cilostamide, a cyclic nucleotide phosphodiesterase 3 inhibitor, in a rat balloon double-injury model. British journal of pharmacology, 2000, Volume: 130, Issue:2 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Catheterization; Cell Count; Cells, Cultured; Cyclic Nucleotide Phosphodiesterases, Type 3; Disease Models, Animal; Hyperplasia; Male; Muscle, Smooth, Vascular; Phosphodiesterase Inhibitors; Proliferating Cell Nuclear Antigen; Quinolones; Rats; Rats, Sprague-Dawley; Time Factors; Tunica Intima	2000
Quinolones: novel probes in antifilarial chemotheraphy. Journal of medicinal chemistry, 2000, Jun-01, Volume: 43, Issue:11 Topics: Animals; Disease Models, Animal; Female; Filariasis; Filaricides; Male; Muridae; Quinolones	2000
Positive effect of rebamipide on gastric permeability in mice after eradication of Helicobacter felis. Scandinavian journal of gastroenterology, 2000, Volume: 35, Issue:5 Topics: Alanine; Animals; Anti-Ulcer Agents; Disease Models, Animal; Gastric Mucosa; Helicobacter; Helicobacter Infections; Mice; Mice, Inbred C57BL; Permeability; Quinolones	2000
[The chemotherapeutic efficacy of ciprofloxacin and lomefloxacin in the inhalation method of infecting white mice with tularemia]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2000, Volume: 45, Issue:6 Topics: Aerosols; Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Drug Evaluation, Preclinical; Fluoroquinolones; Mice; Particle Size; Quinolones; Research Design; Tularemia	2000
Rebamipide, an antiulcer drug, prevents DSS-induced colitis formation in rats. Digestive diseases and sciences, 2000, Volume: 45, Issue:8 Topics: Alanine; Animals; Anti-Ulcer Agents; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Interleukin-1; Interleukin-8; Male; Peroxidase; Quinolones; Rats; Rats, Wistar	2000
Immunomodulatory effects of moxifloxacin in comparison to ciprofloxacin and G-CSF in a murine model of cyclophosphamide-induced leukopenia. European journal of haematology, 2001, Volume: 66, Issue:5 Topics: Animals; Anti-Infective Agents; Aza Compounds; Bone and Bones; Bone Marrow Cells; Cell Count; Ciprofloxacin; Culture Media, Conditioned; Culture Techniques; Cyclophosphamide; Cytokines; Disease Models, Animal; Fluoroquinolones; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Granulocytes; Hematopoiesis; Hematopoietic Stem Cells; Humans; Immunity; Interleukin-6; Leukocyte Count; Leukopenia; Lung; Male; Mice; Mice, Inbred BALB C; Moxifloxacin; Quinolines; Quinolones; Spleen; Urinary Bladder	2001
BMS-284756 (T-3811ME) a new fluoroquinolone: in vitro activity against Legionella, efficacy in a guinea pig model of L. pneumophila pneumonia and pharmacokinetics in guinea pigs. The Journal of antimicrobial chemotherapy, 2001, Volume: 48, Issue:5 Topics: Animals; Anti-Infective Agents; Culture Media; Disease Models, Animal; Fluoroquinolones; Guinea Pigs; Indoles; Legionella pneumophila; Legionnaires' Disease; Male; Quinolones	2001
Efficacies of BMS 284756 against penicillin-sensitive, penicillin-resistant, and quinolone-resistant pneumococci in experimental meningitis. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:1 Topics: 4-Quinolones; Animals; Anti-Infective Agents; Disease Models, Animal; Fluoroquinolones; Indoles; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Rabbits; Streptococcus pneumoniae; Treatment Outcome	2002
[The expression of RAR beta mRNA in rat tongue carcinogenesis]. Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology, 2000, Volume: 35, Issue:5 Topics: 4-Nitroquinoline-1-oxide; Animals; Carcinoma, Squamous Cell; Disease Models, Animal; Down-Regulation; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Retinoic Acid; RNA, Messenger; Tongue Neoplasms	2000
[Telomerase activity in rat tongue carcinogenesis]. Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology, 2000, Volume: 35, Issue:6 Topics: 4-Nitroquinoline-1-oxide; Animals; Biomarkers, Tumor; Disease Models, Animal; Quinolones; Rats; Rats, Sprague-Dawley; Telomerase; Tongue Neoplasms	2000
The synthesis and structure-activity relationships of 4-aryl-3-aminoquinolin-2-ones: a new class of calcium-dependent, large conductance, potassium (maxi-K) channel openers targeted for post-stroke neuroprotection. Bioorganic & medicinal chemistry letters, 2002, Jul-08, Volume: 12, Issue:13 Topics: Animals; Brain; Clone Cells; Disease Models, Animal; Electrophysiology; Large-Conductance Calcium-Activated Potassium Channels; Male; Membrane Potentials; Neuroprotective Agents; Oocytes; Patch-Clamp Techniques; Potassium Channels, Calcium-Activated; Quinolones; Rats; Stroke; Structure-Activity Relationship; Xenopus laevis	2002
Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase. British journal of pharmacology, 1992, Volume: 107, Issue:4 Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Bronchoconstriction; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Guinea Pigs; Hydroxyurea; Inflammation; Knee Joint; Leukotriene B4; Lipoxygenase Inhibitors; Macrophages; Male; Mice; Oxidation-Reduction; Pyrans; Quinolones; Rabbits; Rats; Thromboxane B2	1992
Therapeutic effects of oral rebamipide and in combination with cimetidine on experimental gastritis in rats. Research communications in chemical pathology and pharmacology, 1992, Volume: 78, Issue:3 Topics: Administration, Oral; Alanine; Animals; Anti-Ulcer Agents; Cimetidine; Disease Models, Animal; Drug Therapy, Combination; Gastric Acidity Determination; Gastric Juice; Gastric Mucosa; Gastritis, Atrophic; Male; Quinolones; Rats; Rats, Wistar; Taurocholic Acid	1992
In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:12 Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Female; Fluoroquinolones; Leukopenia; Lung; Mice; Mice, Inbred C57BL; Penicillin Resistance; Pneumonia, Pneumococcal; Quinolones; Species Specificity; Streptococcus pneumoniae	1992
Sparfloxacin, ethambutol, and cortisol receptor inhibitor RU-40 555 treatment for disseminated Mycobacterium avium complex infection of normal C57BL/6 mice. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:11 Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Feasibility Studies; Female; Fluoroquinolones; Glucocorticoids; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mifepristone; Mycobacterium avium; Quinolones; Receptors, Glucocorticoid; Spleen; Time Factors; Tuberculosis	1992
Activity of clarithromycin against Mycobacterium avium complex infection in beige mice. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:11 Topics: Amikacin; Animals; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Clofazimine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Humans; Mice; Mice, Inbred C57BL; Mycobacterium avium; Mycobacterium avium Complex; Quinolones; Rifabutin; Rifampin; Rifamycins; Time Factors; Tuberculosis	1992
Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1992, Volume: 60, Issue:4 Topics: Animals; Clarithromycin; Disease Models, Animal; Female; Fluoroquinolones; Foot; Hindlimb; Immunocompetence; Leprostatic Agents; Leprosy; Mice; Microbial Sensitivity Tests; Minocycline; Mycobacterium leprae; Ofloxacin; Quinolones; Rifampin	1992
Pharmacokinetics of quinolone derivatives in the prostate. Infection, 1991, Volume: 19 Suppl 3 Topics: Animals; Biological Transport; Body Fluids; Disease Models, Animal; Dogs; Humans; Hydrogen-Ion Concentration; Male; Prostate; Quinolones; Tissue Distribution	1991
[Chromosomal resistance of plague agent to quinolones]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1991, Volume: 36, Issue:8 Topics: Animals; Chromosomes, Bacterial; Culture Media; Disease Models, Animal; Drug Resistance, Microbial; In Vitro Techniques; Mice; Models, Genetic; Mutation; Plague; Quinolones; Yersinia pestis	1991
Pharmacokinetics of four fluoroquinolones in an animal model of infected lung. The Journal of antimicrobial chemotherapy, 1991, Volume: 28 Suppl C Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Fluoroquinolones; Lung Diseases; Mice; Mice, Inbred Strains; Ofloxacin; Pneumococcal Infections; Quinolones; Streptococcus pneumoniae	1991
Comparative activity of fluorinated quinolones in acute and subacute Streptococcus pneumoniae pneumonia models: efficacy of temafloxacin. The Journal of antimicrobial chemotherapy, 1991, Volume: 28 Suppl C Topics: Acute Disease; Animals; Anti-Infective Agents; Disease Models, Animal; Female; Fluoroquinolones; Mice; Mice, Inbred Strains; Ofloxacin; Pneumonia; Quinolones; Streptococcus pneumoniae	1991
Antipneumococcal activity of ciprofloxacin, ofloxacin, and temafloxacin in an experimental mouse pneumonia model at various stages of the disease. The Journal of infectious diseases, 1991, Volume: 163, Issue:2 Topics: Amoxicillin; Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Erythromycin; Female; Fluoroquinolones; Lung; Mice; Mice, Inbred C57BL; Ofloxacin; Pneumonia, Pneumococcal; Quinolones; Sepsis; Streptococcus pneumoniae	1991
Effect of nedocromil sodium on early and late phase responses to allergen challenge in the guinea-pig. Drugs, 1989, Volume: 37 Suppl 1 Topics: Allergens; Animals; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Disease Models, Animal; Guinea Pigs; Nedocromil; Ovalbumin; Quinolones; Time Factors	1989
Development of preclinical models for testing antiasthma drugs. Drugs, 1989, Volume: 37 Suppl 1 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Disease Models, Animal; Dogs; Macaca mulatta; Nedocromil; Quinolones	1989
Activation of brain function by S-135, a benzodiazepine receptor inverse agonist. Progress in neuro-psychopharmacology & biological psychiatry, 1988, Volume: 12, Issue:6 Topics: Animals; Antidepressive Agents; Avoidance Learning; Brain; Cerebral Cortex; Deoxyglucose; Depression; Disease Models, Animal; Isometric Contraction; Male; Mice; Mice, Inbred Strains; Motor Activity; Muscle Contraction; Muscles; Pyrazoles; Quinolones; Rats; Rats, Inbred Strains; Receptors, GABA-A; Reflex; Reserpine; Seizures; Synaptosomes	1988
Effects of MY-5116 on experimental asthma in rats and guinea pigs. Arerugi = [Allergy], 1986, Volume: 35, Issue:10 Topics: Animals; Asthma; Cromolyn Sodium; Disease Models, Animal; Female; Guinea Pigs; Histamine Antagonists; Male; Quinolines; Quinolones; Rats	1986
Activity of E-3846, a new fluoroquinolone, in vitro and in experimental cystitis and pyelonephritis in rats. Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:5 Topics: Animals; Anti-Infective Agents; Anti-Infective Agents, Urinary; Bacteria; Chemical Phenomena; Chemistry; Ciprofloxacin; Cystitis; Disease Models, Animal; Enterobacteriaceae; Escherichia coli Infections; Female; Fluoroquinolones; Hydrogen-Ion Concentration; Klebsiella Infections; Norfloxacin; Proteus Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Pyelonephritis; Quinolines; Quinolones; Rats; Rats, Inbred Strains; Staphylococcus; Streptococcal Infections; Streptococcus	1988